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Abstract	  	   Neovascularization	   is	   a	   crucial	   step	   towards	   recovery	   of	   injured	   tissues.	   Since	  endothelial	  cells	   (ECs)	  are	  primary	  angiogenic	  cells,	   their	  delivery	  has	  been	  prominently	  studied	  as	  a	  pro-­‐angiogenic	  strategy.	  Yet,	  up	  to	  now,	  clinical	  trials	  of	  ECs	  transplantation	  have	   not	   resulted	   in	   consistent	   benefits.	   The	   outcome	   might	   presumably	   be	   improved	  using	   biomaterial-­‐based	   vehicles	   to	   protect	   cells	   from	   the	   harsh	   in	   vivo	   environment,	  enhancing	   their	   survival	   and	   engraftment.	   These	   carriers	   might	   also	   provide	   ECs	   with	  instructive	   signals	   to	   assist	   and	   promote	   their	   3D	   organization,	   enhancing	   functional	  integration.	  Alginate	   is	   an	   injectable	   polymer,	   widely	   used	   for	   cell	   entrapment,	   which	   is	  biologically	   inert	   but	   can	   be	   modified	   in	   order	   to	   stimulate	   specific	   cellular	   responses,	  namely	   through	   changes	   in	   its	   viscoelastic	   properties	   and/or	   grafting	   of	   bioactive	  peptides.	   In	   particular,	   previous	   studies	   showed	   that	   3D	   culture	   in	   soft	   RGD-­‐alginate	  hydrogels	  promote	  the	  self-­‐assembly	  of	  entrapped	  cells,	   including	  ECs	  and	  mesenchymal	  stem	   cells	   (MSC),	   and	   the	   deposition	   of	   an	   endogenous	   fibronectin-­‐rich	   extracellular	  matrix	  (ECM)	  by	  MSCs.	  Therefore,	  the	  main	  aim	  of	  this	  work	  was	  to	  create	  an	  ideal	  microenvironment	  for	  EC	  entrapment	  using	  an	  integrative	  approach,	  combining	  this	  optimized	  hydrogel	  matrix	  with	  the	  use	  of	  co-­‐entrapped	  MSCs	  as	  mural	  cells.	  A	  variety	  of	  cell	  populations	  have	  been	  investigated	  in	  clinical	  revascularization	  trials.	  Here,	  the	  initial	  plan	  was	  to	  test	  two	  different	  cell	  types:	  human	  umbilical	  vein	  endothelial	  cells	  (HUVECs),	  a	  well-­‐established	  model	  of	  mature	  ECs,	  and	  endothelial	  progenitor	  cells	  (EPCs)	  derived	   from	  human	  umbilical	   cord	  blood	   (UCB),	  which	   appear	   to	  have	   superior	  angiogenic	   properties	   than	   fully	   differentiated	   ECs	   such	   as	  HUVECs.	   UCB	   is	   a	   promising	  source	   of	   EPCs	   for	   therapeutic	   applications,	   as	   cells	   can	   be	   obtained	   through	   a	   non-­‐invasive	   procedure,	   support	   long-­‐term	   storage	  without	   losing	   biological	   properties,	   and	  have	   low	   immunogenicity,	   which	   makes	   them	   an	   interesting	   candidate	   for	   allogeneic	  transplantation.	   So,	   the	   first	   step	  was	   to	   isolate	   and	   characterize	   CD34+	   cells	   from	  UCB,	  and	   promote	   their	   differentiation	   into	   EPCs,	   which	   was	   performed	   using	   a	   previously	  published	   protocol.	   The	   isolated	   CD34+	   cells	   were	   able	   to	   form	   different	   hematopoietic	  colonies,	   in	   a	   standard	  methylcellulose	   assay,	   which	   confirmed	   their	   multipotency.	   The	  evaluation	  of	  phenotypic	  expression	  before	  and	  after	  a	  differentiation	  period	  of	  21	  days	  showed	  that	  differentiated	  CD34+	  cells	  expressed	  some	  EC-­‐lineage	  markers	  like	  CD31,	  VE-­‐cadherin,	   vWF	  and	  uptake	  of	  Ac-­‐LDL	  and	  presented	   cluster	   formation	  with	   surrounding	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spindle-­‐shaped	   cells.	   Also,	   these	   cells	   were	   not	   able	   to	   form	   tube-­‐like	   structures	   in	  Matrigel	   at	   any	   time-­‐point.	   Overall,	   CD34+	   -­‐derived	   cells	   phenotype	   resembled	   the	   so-­‐called	  early	  EPCs.	  Subsequently,	  soft	  RGD-­‐alginate	  hydrogels	  were	  used	  as	  matrices	  for	  the	  3D	  culture	  of	  ECs.	   HUVECs	   were	   cultured	   alone	   or	   in	   combination	   with	   MSCs,	   whose	   pro-­‐angiogenic	  effects	  and	  pericyte-­‐like	  roles	  have	  been	  widely	  reported.	  Cells	  viability	  and	  functionality	  were	  increased	  in	  co-­‐cultured	  constructs,	  where	  the	  formation	  of	  multicellular	  structures,	  including	   EC	   cord-­‐like	   structures,	   and	   deposition	   of	   endogenous	   ECM	   were	   also	  stimulated.	  When	   placed	   in	   a	   tissue	  mimic	   (Matrigel),	   co-­‐cultures	   also	   promoted	   higher	  outward	  migration	   and	   cell	   sprouting.	   3D	   cultures	   of	   CD34+	   cells	   in	  monoculture	   or	   co-­‐cultured	  with	  MSC	  were	  also	  established.	  However,	  only	  freshly	  isolated	  CD34+	  cells	  were	  tested	  in	  a	  preliminary	  study,	  not	  only	  because	  it	  was	  important	  to	  assess	  how	  these	  cells	  behaved	   in	   soft-­‐RGD	   alginate	  matrices,	   but	   also	   because	   the	   differentiation	   process	  was	  too	   lengthy	   to	  be	   implemented	   in	  3D	  cultures	   in	  due	   time.	  Although	  CD34+	   cells	  did	  not	  perform	  well	  in	  3D	  monocultures,	  interesting	  results	  were	  obtained	  when	  these	  were	  co-­‐cultured	  with	  MSCs,	  and	  both	  cell	  types	  seemed	  to	  exert	  some	  influence	  over	  each	  other.	  Finally,	  a	  preliminary	  characterization	  of	   the	   in	  vivo	  performance	  of	  cell-­‐laden	  soft	  RGD-­‐alginate	   hydrogels	   was	   carried	   out	   using	   the	   chorioallantic	   membrane	   (CAM)	   assay.	  Matrices	  were	  implanted	  immediately	  after	  preparation	  or	  following	  a	  pre-­‐culture	  time	  of	  5	  days,	  and	  their	  angiogenic	  potential	  was	  evaluated.	  Although	  no	  significant	  differences	  were	   found	   between	   the	   different	   types	   of	   cultures	   (mono-­‐	   vs.	   co-­‐cultures),	   the	   pre-­‐cultured	  matrices	  seemed	  to	  result	  in	  an	  increased	  stimulation	  of	  new	  vessels	  formation,	  suggesting	  that	  it	  might	  be	  advantageous	  to	  implant	  more	  mature	  cellular-­‐ECM	  structures.	  	  	  	  
Resumo	  	   Quando	   se	   pretende	   regenerar	   tecidos	   lesionados,	   a	   estimulação	   da	  neovascularização	  é	  um	  passo	  crucial.	  Tendo	  em	  conta	  que	  as	  principais	  células	  envolvidas	  no	  processo	  de	  angiogénese	  são	  células	  endoteliais	  (ECs),	  a	  transplantação	  das	  mesmas	  é	  uma	  das	  estratégias	  mais	  estudadas	  hoje	  em	  dia.	  Contudo,	  até	  hoje,	  os	  ensaios	  clínicos	  que	  envolveram	  o	  transplante	  de	  ECs	  não	  conseguiram	  assegurar	  os	  seus	  benefícios.	  Uma	  das	  maneiras	  de	  melhorar	  os	  resultados	  obtidos	  poderá	  ser,	  então,	  a	  utilização	  de	  biomateriais	  como	  veículos	  que	  protejam	  as	  células	  do	  ambiente	  hostil	   in	  vivo	  e	  permitam	  melhorar	  a	  sua	   sobrevivência	   e	   integração.	  Para	   além	  disso,	   estes	   veículos	  poderão	   ser	  modificados	  com	  sinais	  que	  orientem	  e	  suportem	  a	  sua	  organização	  em	  3D,	  melhorando	  a	   integração	  do	  sistema.	  O	  alginato	  é	  um	  polímero	  injetável	  natural	  muito	  usado	  para	  encapsular	  células.	  Este	  polímero	  é	  biologicamente	  inerte,	  podendo	  ser	  modificado	  de	  forma	  a	  estimular	  respostas	  celulares	   específicas	   e	   desejáveis	   através	   de	   ajustes	   nas	   suas	   capacidades	   viscoelásticas	  e/ou	   por	   adição	   de	   péptidos	   bioativos	   às	   suas	   cadeias.	   Mais	   especificamente,	   estudos	  recentes	   com	   células	   endoteliais	   e	   mesenquimais	   estaminais	   (MSCs)	   mostraram	   que	  culturas	  3D	  em	  hidrogeis	  suaves	  de	  RGD-­‐alginato	  promovem	  a	  reorganização	  das	  células	  e	  estimulam	  a	  deposição	  de	  uma	  matriz	  extracelular	  (ECM)	  endógena,	  rica	  em	  fibronectina,	  por	  MSCs.	  Assim	   sendo,	   o	   principal	   objectivo	   deste	   trabalho	   seria	   o	   de	   criar	   o	  microambiente	  ideal	   para	   a	   encapsulação	   de	   ECs,	   combinando	   os	   conhecimentos	   relativos	   à	   matriz	   de	  hidrogel	  optimizada	  com	  o	  uso	  de	  MSCs	  como	  células	  murais.	  Hoje	  em	  dia,	  já	  foram	  testados	  vários	  tipos	  de	  células	  em	  ensaios	  clínicos	  com	  vista	  a	  revascularização.	   Neste	   estudo,	   o	   plano	   inicial	   era	   o	   de	   testar	   dois	   tipos	   de	   células	  humanas:	  células	  endoteliais	  da	  veia	  do	  cordão	  umbilical	  (HUVECs)	  e	  células	  progenitoras	  endoteliais	  (EPCs)	  derivadas	  do	  sangue	  do	  cordão	  umbilical	  (UCB),	  sendo	  que	  a	  primeira	  população	  é	   correntemente	  usada	  como	  modelo	  de	  ECs	  maduras	  e	  a	   segunda,	  apesar	  de	  parecer	  possuir	  mais	  propriedades	  angiogénicas,	  ainda	  não	  se	  encontrar	  bem	  definida.	  O	  facto	   de	   as	   EPCs	   poderem	   ser	   isoladas	   de	   uma	   fonte	   rica	   em	   células	   progenitoras	   como	  UCB	   é	   uma	   grande	   vantagem	  pois	   permite	   a	   obtenção	   de	   células	   não	   imunogénicas	   por	  meios	   não	   invasivos.	   Para	   além	   disso,	   as	   EPCs	   podem	   ser	   armazenadas	   por	   longos	  períodos	  de	  tempo	  sem	  perder	  propriedades	  biológicas.	  Todos	  estes	  factores	  fazem	  destas	  células	  as	   candidatas	   ideais	  para	   transplantes	  alogénicos.	  Desta	   forma,	  o	  primeiro	  passo	  deste	  trabalho	  foi	  isolar,	  caracterizar	  as	  células	  CD34+	  presentes	  no	  UCB	  e	  promover	  a	  sua	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diferenciação	   em	   EPCs	   segundo	   um	   protocolo	   previamente	   publicado.	   A	   análise	   do	  fenótipo	   exibido	   antes	   e	   depois	   de	   um	  período	  de	   diferenciação	   de	   21	  dias	   demonstrou	  que	   as	   células	   diferenciadas	   a	   partir	   de	   células	   CD34+	   exprimiram	   marcadores	  característicos	  de	  linhagens	  endoteliais	  como	  CD31,	  VE-­‐caderina,	  vWF,	  incorporaram	  Ac-­‐LDL	  e	  formaram	  agregados	  de	  células	  rodeados	  de	  células	  fusiformes.	  Para	  além	  disso,	  as	  células	   CD34+	   formaram	   colónias	   hematopoiéticas,	   e	   nem	   estas	   nem	   as	   células	  diferenciadas	   conseguiram	   formar	   estruturas	   tubulares	   em	   Matrigel.	   De	   uma	   maneira	  geral,	  as	  células	  derivadas	  de	  células	  CD34+	  apresentaram	  um	  fenótipo	  semelhante	  ao	  das	  	  EPCs	  precoces.	  De	   seguida,	   hidrogeis	   moles	   de	   RGD-­‐alginato	   foram	   usados	   como	   matrizes	   para	   a	  cultura	  3D	  de	  ECs.	  HUVECs	  foram	  postas	  em	  cultura	  sozinhas	  ou	  em	  co-­‐cultura	  com	  MSCs,	  cujos	   efeitos	   pro-­‐angiogénicos	   e	   capacidade	   de	   atuar	   como	   pericitos	   foram	   vastamente	  reportados.	  A	  viabilidade	  e	   funcionalidade	  das	   células	   em	  co-­‐cultura	   foram	  aumentados,	  da	   mesma	   maneira	   que	   foram	   estimuladas	   a	   formação	   de	   estruturas	   multicelulares	  tubulares,	  	  formadas	  por	  ECs,	  e	  deposição	  de	  ECM	  endógena.	  Quando	  estas	  matrizes	  foram	  colocadas	   em	  Matrigel,	   a	   co-­‐cultura	   também	  promoveu	  maior	  migração	   para	   o	   exterior.	  Células	   CD34+	   foram	   também	   testadas	   em	   culturas	   3D,	   sozinhas	   ou	   em	   co-­‐cultura	   com	  MSCs.	  No	   entanto,	   só	   foram	  utilizadas	   células	   isoladas	   no	  momento,	   por	   ser	   importante	  analisar	  o	  seu	  comportamento	  nas	  matrizes	  utilizadas,	  mas	  também	  por	  o	  seu	  processo	  de	  diferenciação	  ser	  demasiado	  demorado	  para	  ser	  implementado	  em	  culturas	  3D	  a	  tempo.	  	  Apesar	   de	   o	   comportamento	   das	   células	   CD34+	   não	   ter	   sido	   satisfatório	   em	  monocultura	  3D,	  foram	  obtidos	  resultados	  interessantes	  quando	  em	  co-­‐cultura	  com	  MSCs,	  e	  ambos	  os	  tipos	  celulares	  pareceram	  exercer	  algum	  tipo	  de	  influência	  um	  sobre	  o	  outro.	  Por	  fim,	  foi	  feita	  uma	  caracterização	  preliminar	  da	  performance	  dos	  hidrogeis	  moles	  de	  RGD-­‐alginato	   com	  células	  embebidas	   in	  vivo,	   utilizando	  o	  ensaio	  na	  membrana	  corio-­‐alântica	  de	  um	  embrião	  de	  galinha.	   	  As	  matrizes	   foram	  implantadas	   imediatamente	  após	  preparação	  ou	  após	  um	  período	  de	  pré-­‐cultura	  de	  5	  dias,	  e	  o	  seu	  potencial	  de	  angiogénese	  foi	  avaliado.	  Apesar	  de	  não	  se	  terem	  detectado	  diferenças	  significativas	  entre	  os	  tipos	  de	  cultura	  (mono-­‐	  e	  co-­‐cultura),	  as	  matrizes	  previamente	  preparadas	  pareceram	  aumentar	  	  a	  estimulação	   da	   formação	   de	   novos	   vasos	   sanguíneos,	   indicando	   que	   talvez	   possa	   ser	  vantajosa	  a	  implantação	  de	  matrizes	  contendo	  estruturas	  de	  ECM	  mais	  maduras.	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   Fibronectin	  GA	   	   Gentamicin	  Amphotericin	  GDL	  	  	   	   Glucone	  Delta-­‐Lactone	  GEMM	   	   Granulocyte,	  Eritrocyte,	  Monocyte,	  Megakaryocyte	  GM	   	   Granulocyte,	  Macrophage	  HMW	  	   	  	   High	  Molecular	  Weight	  HSC	   	   Hematopoietic	  Stem	  Cells	  HUVECs	  	  	   Human	  Umbilical	  Vein	  Endothelial	  Cells	  IFM	  	  	   	   Inverted	  Fluorescence	  Microscope	  IGF	   	   Insulin	  Growth	  Factor	  IMDM	  	   	  	   Iscoves	  Modified	  Dulbecco’s	  Medium	  
	  	   X	  
LMW	  	  	   	   Low	  Molecular	  Weight	  MC	  	  	   	   Mural	  Cells	  MMP	  	  	   	   Matrix	  Metalloproteinase	  MNCs	  	   	  	   Mononuclear	  Cells	  MSCs	  	  	   	   Human	  Mesenchymal	  Stem	  Cells	  PFA	  	  	   	   Paraformaldehyde	  PI	  	  	   	   Propidium	  Iodide	  PBS	  	  	   	   Phosphate	  Buffered	  Saline	  Pen/Strep	  	  	   Penicillin/Streptomycin	  RGD	  	  	   	   Arginylglycylaspartic	  acid	  RT	  	  	   	   Room	  Temperature	  SD	  	  	   	   Supplementary	  Data	  TBS	  	  	   	   Tris-­‐Buffered	  Saline	  UCB	  	  	   	   Umbilical	  Cord	  Blood	  VE-­‐cad	  	  	   Vascular	  Endothelial	  Cadherin	  VEGF	  	  	   	   Vascular	  Endothelial	  Growth	  Factor	  vWF	  	  	   	   Von	  Willebrand	  Factor	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1.	  DINAMICS	  OF	  NEOVASCULARISATION	  	  	   Angiogenesis	  is	  the	  physiological	  process	  that	  leads	  to	  formation	  of	  new	  blood	  vessels	  from	   pre-­‐existing	   vasculature	   in	   post-­‐embryonic	   development.	   Blood	   vessels	   provide	  adequate	  oxygenation,	  nutrient	  delivery	  and	  removal	  of	  waste	  products	  in	  surrounding	  cells,	  as	  well	   as	   signaling	  molecules	   that	  might	   be	   involved	   in	   communication	   between	   organs.	  The	  importance	  of	  vascularization	  is	  based	  on	  the	  fact	  that	  diffusion	  between	  blood	  vessels	  and	  the	  surrounding	  cells	  is	  limited	  to	  a	  distance	  of	  up	  to	  150-­‐300	  µm	  [1].	  	  When	  new	  blood	  vessels	  are	  formed,	  it	  can	  happen	  either	  from	  the	  longitudinal	  splitting	  of	  an	  existing	  vessel	  –	  intussusceptive	  angiogenesis	  –	  or	  from	  the	  outgrowth	  of	  a	  new	  branch	  from	  preexisting	  blood	  vessels	  –	  sprouting	  angiogenesis.	  Yet,	  both	  of	  these	  processes	  occur	  via	   proliferation	   and	   migration	   of	   endothelial	   cells	   (ECs),	   which	   can	   be	   influenced	   by	  interaction	   with	   their	   extracellular	   matrix	   (ECM)	   [2]	   and	   involves	   the	   release	   of	   matrix	  metalloproteinases	   (MMP)	   by	   ECs	   to	   degrade	   the	   ECM	   [3].	   Communication	   between	   ECs,	  between	   ECs	   and	   other	   cells	   and	   between	   cells	   and	   ECM	   is	   vital	   throughout	   the	   entire	  process.	  	  Vasculogenesis	   is	   other	   type	   of	   neovascularization	   that	   happens	   more	   frequently	   in	  embryonic	   development	   (although	   reports	   have	   been	  made	   of	   its	   occurrence	   in	   adult	   life	  [4]),	   and	  consists	   in	   the	  de	  novo	   formation	  of	  blood	  vessels	   from	  angioblasts:	   endothelial	  progenitor	   cells	   form	  blood	   islands	   that	   fuse	   and	   sprout,	   forming	   a	   primary	   plexus	   that	  later	  expands	  via	  angiogenesis	  and	  vasculogenesis	  [5].	  In	  this	  case,	  endothelial	  progenitor	  cells	  (EPCs)	  are	  mobilized	  to	  sites	  of	  neovascularization	  and	  differentiate	  into	  ECs	  in	  situ	  –	  see	  Figure	  1.	  	  Mature	   endothelial	   vessels	   are	   formed	   by	   an	   endothelial	   layer	   that	   is	   stabilized	   by	  mural	   cells	   (which	   depend	   on	   the	   size	   of	   tube:	   pericytes	   in	   cappilaries	   and	   vascular	  smooth	  muscle	   cells	   in	  more	   complex	   vessels)	   and	   a	   basement	  membrane	   that	   embeds	  them	  [6].	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2.	  NEOVASCULARISATION	  AS	  A	  TISSUE	  REGENERATION	  STRATEGY	  	   The	   main	   goal	   of	   tissue	   engineering	   strategies	   is	   to	   repair	   damaged,	   injured	   or	  missing	  body	  tissues	  in	  a	  way	  that	  its	  functions	  maintain	  assured.	  Engineered	  tissues	  of	  a	  clinically	  relevant	  size	  and	  complexity	  must	  have	  their	  own	  vasculature	  or	  easily	  develop	  it	   after	   implantation,	   allowing	   rapid	   and	   stable	   perfusion	   so	   that	   the	   area	   and	   its	  surrounding	   tissue	   is	   repopulated,	   preventing	   cell	   death	   and	   tissue	   necrosis.	   Many	  approaches	   have	   been	   devised	   in	   order	   to	   improve	   angiogenesis	   and	   vasculogenesis	   in	  bioengineered	  tissues	  for	  later	  implantation,	  taking	  into	  consideration	  the	  knowledge	  	  on	  phisiological	  mechanisms	  of	  neovascularisation.	  	  Implants	  can	  present	  neovascularization	  that	  results	  from	  either	  the	  invasion	  of	  host	  blood	  vessels	  and/or	  neovascularization	  in	  vivo,	  or	  from	  the	  prevascularization	  in	  vitro	  or	  
in	   vivo	   before	   implantation	   [6].	   Figure	   2	   depicts	   the	   main	   cell-­‐based	   approaches	   to	  promote	   neovascularization	   of	   a	   bioengineered	   tissue.	   Also,	   Novosel	   et	   al.	   published	   a	  review	   that	   delves	   into	   these	   subjects	   [1].	   Prevascularization	   is	   of	   great	   importance	   in	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thick	  constructs,	  since	  it	  accelerates	  functional	  anastomosis,	  through	  connection	  with	  the	  host	  existing	  vasculature	  upon	  implantation.	  Prevascularization	  can	  be	  stimulated	  by	  cell	  seeding	  and	  neovascularization	  stimulation	  in	  vitro	  (Figure	  7-­‐A)	  [7],	  or	  by	  implantation	  of	  unseeded	   scaffolds	   into	   a	   host	   body	   (Figure	   7-­‐B).	   Host	   blood	   vessels	   penetrate	   the	  scaffold,	   building	   a	   perfusable	   vascular	   network,	   and	   these	   scaffolds	   are	   then	   explanted	  and	  reimplanted	  into	  the	  ischemic	  target	  site	  [1].	  	  Anyhow,	   neovascularization	   in	  vitro	   or	   in	  vivo,	   can	   be	   achieved	   by	   seeding	   relevant	   cell	  types	  in	  the	  target	  area.	  Endothelial	  cells	  (ECs)	  compose	  the	  inner	  lining	  of	  blood	  vessels,	  and	   secrete	   several	   paracrine	   factors	   (such	   as	   growth	   factors)	   that	   are	   known	   to	   be	  involved	  in	  the	  stimulation	  of	  angiogenesis	  –	  hence,	  these	  are	  the	  most	  comon	  “single-­‐cell-­‐type”	  cultures	  used	  for	  angiogenesis	  stimulation	  assays	  [8].	  However,	  it	  is	  known	  that	  ECs	  and	  their	  progenitors	  (EPCs)	  are	  not	  the	  only	  cells	  involved	  in	  neovascularization	  and	  that	  more	  cell	  types	  are	  found	  in	  mature	  blood	  vessels,	  leading	  to	  the	  use	  of	  more	  than	  one	  cell	  type	  in	  these	  assays	  (Figure	  7-­‐E).	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The	   ECM	   that	   surrounds	   blood	   vessels	   consists	   mostly	   of	   hydrated	   proteins	   and	  proteoglycans,	  yet	  is	  responsible	  for	  mechanical	  and	  biochemical	  stimuli	  that	  regulate	  cell	  behavior	  [9].	  The	  influence	  of	  grafted	  growth	  factors	  (Figure	  7-­‐C)	  and	  adhesion	  peptides	  (Figure	   7-­‐D)	   that	   stimulate	   scaffold-­‐cells	   interaction	   on	   angiogenesis	   is	   a	  major	   subject	  currently	   under	   study,	   in	   order	   to	   fully	   understand	   and	   ultimately	   mimic	   the	   normal	  biological	  processes	  occurring	  inside	  the	  body	  during	  neovascularization	  [6].	  	  	  
3.	   ENDOTHELIAL	   CELL	   DELIVERY	   TOWARDS	   NEOVASCULARISATION	  
STIMULATION	  	  	  
3.1.	  MATURE	  ENDOTHELIAL	  CELLS	  FOR	  NEOVASCULARISATION	  	  	   For	  neovascularisation	  in	  cell	  delivery	  therapies,	  ECs	  are	  one	  of	  the	  primary	  types	  of	  cells	  to	  be	  seeded.	  Mature	  endothelial	  cells	  have	  limited	  regenerative	  capacity,	  since	  they	  are	  fully	  differentiated,	  and	  their	  phenotype	  is	  slightly	  different	  in	  every	  source.	  Still,	  they	  can	  be	  isolated	  from	  many	  parts	  of	  the	  human	  body,	  such	  as	  the	  umbilical	  vein	  (HUVECs),	  dermal	  microvasculature	  (HDMECs)	  and	  vasculature	   in	  general	  (HVECs),	  and	  are	  easy	  to	  identify.	   Mature	   endothelial	   cells	   preferentially	   express	   some	   genes	   and	   molecular	  markers:	  expression	  of	  CD31,	  CD34,	  von	  Willebrand	   factor	   (vWF)	  and	  dil-­‐acetylated	   low	  density	   lipoprotein	  (Ac-­‐LDL)	  uptake	  are	   the	  most	  common	  markers	  when	  distinguishing	  ECs	   from	   other	   cells	   in	   culture	   using	   flow	   cytometry	   or	   immunohistochemistry.	   Other	  relevant	  markers	  used	   to	  discriminate	  mature	  ECs	  during	  differentiation	  are	  E-­‐selectins,	  VE-­‐cadherin	  (vascular	  endothelial	  cadherin)	  and	  N-­‐cadherin:	  these	  molecules	  are	  involved	  in	  cell	  adhesion	  between	  ECs	  or	  between	  ECs	  and	  other	  cells	  present	  in	  angiogenesis	  like	  pericytes,	   fibroblasts	   and	   smooth	   muscle	   cells	   (SMCs)	   [10].	   Previous	   studies	   from	   our	  group	  where	  HUVECs	  were	  used	  have	   shown	   that	   these	   cells	   can	  proliferate,	   reorganize	  into	  cellular	  networks	  and	  even	  migrate	  	  when	  they	  were	  encapsulated	  into	  alginate	  [11].	  	  A	   comon	   disadvantage	   of	   mature	   endothelial	   cells	   is	   that,	   in	   order	   to	   prevent	   an	  immune	  reaction,	  the	  patient’s	  own	  cells	  would	  have	  to	  be	  collected	  from	  a	  blood	  vessel,	  	  a	  	  process	  that	  	  can	  cause	  morbidity	  at	  the	  donor	  site,	  and	  they	  also	  present	  low	  proliferation	  rates	   and	   low	   availability.	   As	   a	   result	   of	   these	   impairments,	   the	   scientific	   community’s	  attention	  has	  been	  turning	  to	  endothelial	  progenitor	  cells	  (EPCs),	  a	  heterogeneous	  minor	  subpopulation	  of	  blood	  mononuclear	  cells	  (MNCs)	  that	  play	  a	  significant	  role	  in	  postnatal	  vasculogenesis	   [1].	   EPCs	   are	   believed	   to	   be	   mobilized	   to	   damaged	   tissues	   in	   case	   an	  emergent	  vascular	  regenerative	  process	  is	  happening,	  and	  represent	  an	  advantageous	  cell	  type	   for	   cell	   delivery	   therapies,	   since	   blood	   can	   be	   collected	   from	   the	   patient	   and	   these	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cells	  can	  be	  isolated	  and	  expanded	  in	  vitro	  [12];	  this	  way,	  the	  implant	  will	  stimulate	  tissue	  regeneration	   without	   causing	   an	   immune	   response.	   They	   also	   present	   aditional	  advantages,	  as	  detailed	  below.	  
3.2.	  ENDOTHELIAL	  PROGENITOR	  CELLS	  	  	   Since	  Asahara	  et	  al.	  [13]	  originally	  reported	  the	  isolation	  of	  EPCs,	  efforts	  have	  been	  made	  to	  characterize	  each	  type	  of	  cells	  comprised	  under	  the	  term	  “EPCs”.	  However,	  there	  is	  not	  a	  standardized	  isolation	  and	  culture	  protocol	  being	  used	  yet.	  Asahara’s	  group	  claims	  that	  there	  are	  two	  main	  types	  of	  EPCs,	  acording	  to	  their	  origin:	  hematopoietic	  lineage	  EPCs	  and	   nonhematopoietic	   lineage	   EPCs	   [14].	   “Hematopoietic	   EPCs”	   represent	   a	  heterogeneous	   subpopulation	   of	   hematopoietic	   stem	   cells	   (HSCs)	   with	   provasculogenic	  characteristics.	  These	  EPCs	  can	  be	  isolated	  from	  bone	  marrow	  (BM)	  or	  blood	  and	  include	  colony-­‐forming	   EPCs	   (CF-­‐EPCs),	   non-­‐colony	   forming	   “differentianting”	   EPCs	   or	   even	  adherent	  circulating	  angiogenic	  cells	  (CACs),	  among	  others.	  “Nonhematopoietic	  EPCs”	  are	  adhesive	   angiogenic	   and	   vasculogenic	   cells	   that	   present	   mature	   EC-­‐like	   phenotypes	   or	  differentiate	   into	   it.,	   yet	   do	   not	   form	   hematopoietic	   colonies	   in	   methylcelulose.	  Nonhematopoietic	  EPCs	  can	  be	  isolated	  from	  blood	  or	  tissue	  samples;	  however,	  these	  cells	  primary	  origin	  is	  still	  unknown.	  Endothelial	  outgrowth	  cells	  (EOC)	  are	  the	  main	  member	  of	   this	   group	  of	  EPCs.	  Figure	   3	   describes	   the	   general	  EPC	  dynamics:	   although	  all	   of	   the	  EPCs	   seem	   to	   be	   responsive	   to	   stimulation	   that	   causes	   them	   to	   migrate	   to	   damaged	  tissues,	  the	  role	  they	  play	  in	  tissue	  regeneration	  is	  different.	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On	  the	  other	  hand,	  Prater’s	  group	  has	  categorized	  EPCs	  regarding	  their	  phenotype:	  	  early	   EPCs	   and	   late	   EPCs	   [15].	   Accordingly	   to	   this	   classification,	   CF-­‐EPCs	   and	   CACs	  constitute	   early	   EPCs,	   since	   they	   appear	   in	   culture	   after	   4-­‐9	   days.	   Early	   EPCs	   have	  angiogenic	  and	  vasculogenic	  potential,	  are	  capable	  of	  vascular	  integration	  and	  express	  	  EC	  markers,	  but	  do	  not	   form	  tube-­‐like	  structures	  or	  present	  a	   cobblestone-­‐like	  morphology	  when	   in	  culture	   [14]-­‐[16].	  Endothelial	   colony	   forming	  cells	   (ECFCs)	  are	  classified	  as	   late	  EPCs,	  since	  they	  take	  about	  7	  to	  21	  days	  to	  be	  detected	  in	  culture	  [17].	  These	  EPCs	  form	  tube-­‐like	   structures	   in	   culture	   and	   present	   a	   phenotype	   that	   is	   similar	   to	   mature	  endothelial	   lineage	   [15],	   [18].	  Figure	   4	  presents	   common	  methods	  of	  EPC	   culture,	   their	  morphology	  and	  the	  main	  groups	  that	  characterized	  each	  type	  of	  cells.	  
Figure	  4	  –	  Common	  methods	  of	  EPCs	  isolation	  and	  culture.	  Method	  A:	  CFU-­‐ECs	  are	  obtained	  after	  a	  culture	  period	   of	   5-­‐days,	   where	   non-­‐adherent	  MNCs	   differentiate	   into	   adherent	   EPC	   colonies.	   Scale	   bar	   =	   100	   μm.	  Method	  B:	  Circulating	  angiogenic	  cells	  appear	  after	  4-­‐7	  days	  in	  culture,	  and	  typically	  do	  not	  form	  CAC	  cultures.	  Scale	  bar	  =	  200	  μm.	  Method	  C:	  ECFCs	  derive	  from	  adherent	  MNCs	  and	  are	  detected	  after	  7	  to	  21	  days	  in	  culture.	  These	  cells	  usually	  display	  a	  cobblestone-­‐like	  appearance.	  Scale	  bar	  =	  400	  μm.	  Yellow:	  non-­‐adherent	  cells;	  Red:	  
adherent	  cells.	  
Adapted	  from	  Prater	  et	  al.	  	  
Asahara	  Asahara	   Ingram	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Recently,	   several	   groups	   have	   been	   focusing	   in	   CD34+-­‐selected	   populations,	  isolated	   from	   MNCs,	   as	   an	   EPC-­‐enriched	   fraction.	   Even	   though	   this	   marker	   is	   also	  expressed	   on	   hematopoietic	   stem	   and	   progenitor	   cells,	   this	   fraction	   has	   been	   yielding	  positive	  results	  regarding	  neovascularisation	  stimulation	  and	  angiogenesis	  potential	  [19],	  [20].	   However,	   CD34+	   cells	   still	   form	   a	   heterogeneous	   population	   [21],	   and	   their	  differentiation	  and	  phenotype	  varies	  according	  to	  their	  culturing	  method	  [22].	  	  CD34+-­‐derived	   EPCs	   have	   the	   advantage	   of	   being	   isolated	   through	   non-­‐invasive	  means	  [23]	  and	  having	  great	  expansion	  potential.	  However,	  not	  only	  their	  expansion	  and	  maintenance	   is	   more	   successful	   when	   they	   are	   co-­‐cultured	   with	   mesenchymal	   stem	   or	  progenitor	   cells	   (MSCs)	   [24],	   their	   viability	   and	   angiogenic	   behavior	   has	   already	   been	  proven	  to	  be	  increased	  when	  they	  are	  co-­‐cultured	  with	  many	  types	  of	  cells,	  like	  MSCs	  [25],	  CD34-­‐	  cells	  [26]	  and	  even	  CD34+-­‐derived	  ECs	  [20].	  	  	  
3.3.	  CO-­‐CULTURE:	  THE	  SUPPORTING	  ROLE	  OF	  MESENCHYMAL	  STEM	  CELLS	  	  	   So	  far,	  bone	  marrow-­‐derived	  and	  cord	  blood-­‐derived	  MSCs	  were	  proven	  to	  be	  able	  to	  act	   as	  pericytes	   (perivascular	   cells),	   providing	  paracrine	   signals	   that	   stimulate	  ECs	   to	  form	  tubular	  structures,	  and	  promote	  and	  stabilize	  newly	  forming	  structures	  in	  vitro	  and	  in	   vivo	   [23],	   [27].	   The	   stimulation	  MSC-­‐derived	  perivascular	   cells	   confer	   to	   the	   growing	  blood	  vessels	   is	  attained	  by	  secretion	  of	  pro-­‐angiogenic	  cytokines	  and	  regulation	  of	  cell-­‐cell	   adherens	   junctions,	   which	   leads	   to	   regulation	   of	   the	   vessels	   permeability	   and	  perfusion	   and	   makes	   them	   less	   susceptible	   to	   regression.	   Also,	   our	   group	   has	   already	  shown	  that	  MSCs	  can	  self-­‐assemble	  and	  produce	  ECM	  within	  RGD-­‐grafted	  alginate	  [28],	  as	  well	   as	   promote	   multicellular	   networks	   formation	   by	   HUVECs	   when	   encapsulated	   in	  alginate	   microspheres	   [11].	   Another	   advantage	   of	   MSCs	   is	   that	   their	   isolation	   does	   not	  yield	   donor	   site	   morbidity,	   allowing	   us	   to	   use	   the	   patient’s	   own	   cells	   and	   prevent	   an	  immune	  response.	  
3.4.	  CELL	  DELIVERY	  VEHICLES	  	  	   Many	  research	  groups	  have	  tried	  to	  mimic	  the	  ECM	   in	  vitro,	  not	  only	  using	  naturally	  derived	   biomaterials	   but	   also	   synthetic	   biomaterials	   with	   some	   type	   of	   modification;	  however,	  there	  are	  many	  factors	  and	  limitations	  that	  have	  to	  be	  controlled	  [9].	  In	  order	  to	  mimic	   vascularisation	   in	   engineered	   tissues	   and/or	   deliver	   vascular	   cells,	   a	   suitable	  extracellular	   environment	   should	   also	   be	   developed.	   Therefore,	   scaffolds	   should	   ideally	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promote	   cell	   survival,	   allow	   cellular	   reorganization,	   and	   allow	   cell-­‐driven	   remodeling	  processes.	  	  Hydrogels	  can	  be	  formed	  from	  several	  natural	  and	  synthetic	  materials,	  mostly	  under	  mild	  conditions.	  Also,	  they	  are	  easily	  modified	  and	  highly	  permeable	  to	  oxygen	  and	  water-­‐soluble	   molecules.	   From	   the	   range	   of	   possibilities	   within	   hydrogels,	   natural	   hydrogels	  have	   the	   advantage	   of	   innately	   exhibiting	   some	   of	   the	   properties	   that	   characterize	   soft	  tissues	  [29].	  	  Alginate	   is	  one	  of	   the	  most	  widely	  used	  hydrogels:	   it	   is	  a	  polysaccharide,	  derived	  from	  brown	  algae,	  which	  can	  crosslink	  in	  situ	  in	  the	  presence	  of	  divalent	  cations	  (e.g.	  Ca2+),	  with	   low	   toxicity,	   and	   therefore	   can	   be	   injected	   into	   the	   target	   site,	   what	   makes	   it	   a	  minimally	   invasive	   therapy.	   Thanks	   to	   the	   alginate’s	   versatility,	   its	   non-­‐fouling	  characteristics	  and	  non-­‐adhesiveness	  to	  cells	  can	  be	  overcome	  by	  covalently	  modifying	  it	  with	   cell-­‐adhesion	   peptides	   (namely,	   containing	   the	   arginine-­‐glycine-­‐aspartic	   acid	  aminoacid	   sequence	   –	   RDG).	   This	   strategy	   has	   already	   been	   studied	   in	   previous	   works	  within	  our	  group	  [11],	  [30],	   [31].	  Besides	  that,	   it	   is	  also	  possible	  to	  adjust	   its	  mechanical	  properties	   through	   molecular	   weight	   distribution	   and	   partial	   oxidation,	   and	   their	  degradation	   rate	   can	   be	   regulated	   using	   crosslinking	   peptides	   that	   are	   susceptible	   to	  cleavage	   by	   MMPs	   [32].	   Regarding	   injectable	   pro-­‐angiogenic	   therapies,	   these	   hydrogels	  have	  been	  most	  commonly	  tested	  as	  growth-­‐factor	  delivery	  (usually	  VEGF)	  vehicles	  [33],	  [34].	   In	   order	   to	   validate	   these	   hydrogels	   as	   endothelial	   cell	   celivery	   vehicles	   and	   their	  pro-­‐angiogenic	  properties,	  in	  vitro	  and	  in	  vivo	  studies	  have	  to	  be	  performed.	  	  
4.	  PRELIMINARY	  IN	  VIVO	  ASSESSMENT	  OF	  PROANGIOGENIC	  PROPERTIES	  	  	  
In	   vitro	   assays	   have	   the	   advantage	   of	   being	   easy	   to	   interpret	   and	   involving	   well-­‐controlled	  conditions,	  what	  facilitates	  the	  assessment	  of	  angiogenic	  effects	  [35].	  However,	  
in	  vivo	  studies	  have	  to	  be	  performed	  in	  order	  to	  analyze	  the	  host’s	  response	  and	  the	  pro-­‐angiogenic	  properties	  of	  endothelial	  cell	  delivery	  vehicles.	  	  The	   simplest	   and	   most	   extensively	   used	   in	   vivo	   assay	   is	   performed	   in	   the	  chorioallantoic	   membrane	   (CAM)	   of	   a	   chick	   embryo.	   The	   CAM	   is	   an	   extra-­‐embryonic	  membrane	  with	  an	  extensive	  vascular	  network	  that	  grows	  rapidly	  and	  lines	  the	  inner	  shell	  membrane,	  being	  so	  thin	  that	  becomes	  almost	  transparent	  and	  planar.	  To	  implant	  scaffolds	  onto	   the	   CAM,	   a	   window	   is	   opened	   in	   the	   shell,	   exposing	   the	   CAM	   and	   allowing	   the	  placement	   of	   the	   scaffold	   (Figure	  4).	   Afterwards,	   this	   window	   can	   be	   closed	   with	  transparent	   tape	   or	   a	   glass	   slide	   to	   prevent	   dehydration	   [36],	   and	   the	   grafts	   can	   be	  recovered	  after	  an	  appropriate	  length	  of	  incubation	  time.	  Therefore,	  this	  assay	  provides	  an	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easy	   way	   to	   directly	   assess	   and	   quantify	   the	   formation	   of	   blood	   vessels	   using	   stereo-­‐microscopy;	  also,	  the	  embryo’s	  inflamatory	  reaction	  to	  the	  implant	  and	  morphology	  of	  the	  newly	  formed	  vessels	  can	  be	  assessed	  by	  immunocytochemistry.	  Finally,	  fertilized	  specific	  pathogen-­‐free	  (SPF)	  chicken	  eggs	  are	  relatively	  cheap	  and	  easy	  to	  obtain,	  which	  makes	  the	  CAM	  assay	  a	  lot	  more	  appealing	  [37].	  	  For	  all	  of	  the	  above	  reasons,	  the	  CAM	  assay	  is	  the	  best	  stepping	  stone	  between	  in	  vitro	  3D	  studies	  and	  more	  detailed	  in	  vivo	  studies	  with	  a	  mammalian	  model. 
	  
Figure	   5	   –	   Representative	   time-­‐dependent	   diagram	   of	   the	   in	   vivo	   CAM	   assay.	   The	   transplantation	   and	  collection	  of	  the	  hydrogel	  can	  be	  made	  at	  different	  times,	  as	  long	  as	  one	  does	  not	  get	  too	  close	  to	  the	  hatching	  date.	  (LIU,	  XI	  et	  al.)	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1.	  ISOLATION	  AND	  CHARACTERIZATION	  OF	  CD34+	  CELLS	  
	  
1.1.	  ISOLATION	  OF	  MNCS	  FROM	  UCB	  	   Umbilical	  cord	  blood	  samples	  were	  collected	  during	  labor	  at	  Hospital	  S.	  João.	  All	  of	  the	  donors	   signed	   an	   informed	   consent	   form	   that	   is	   in	   compliance	   with	   the	   Portuguese	  legislation	   and	   the	   ethical	   committee	   of	   the	   referred	   hospital	   approved	   the	   collection.	  	  After	   collection,	   the	   samples	   were	   stored	   and	   transported	   in	   250	   mL	   sterile	   bags	   that	  contained	   35	   mL	   of	   CPDA-­‐1	   (Citrate,	   Phosphate,	   Dextrose	   and	   Adenine)	   anti-­‐coagulant	  solution.	  	  Mononuclear	  cells	  were	  isolated	  from	  blood	  using	  Ficoll	  (Histopaque-­‐1077	  Hybri	  Max;	   Sigma-­‐Aldrich,	   St.	   Louis,	   USA)	   density	   gradient	   separation	   (see	   Figure	   S-­‐1,	   in	  
Supplementary	  Data	  –	  SD).	  MNCs	  rings	  were	  pipetted	  onto	  50	  mL	  Falcon	  tubes,	  washed	  with	   twice	   their	   volume	   of	   IMDM	   (Iscoves	   Modified	   Dulbecco’s	   Medium;	   Invitrogen,	  Carlsbad,	   USA)	   and	   afterwards	   resuspended	   in	   CCFM	   (Recovery	   Cell	   Culture	   Freezing	  Medium;	  Invitrogen)	  at	  a	  density	  of	  about	  108	  cells/mL.	  Samples	  were	  frozen	  and	  stored	  at	  -­‐80ºC.	  
1.2.	  ISOLATION	  OF	  CD34+	  CELLS	  FROM	  MNCS	  	   MNCs	   were	   defrosted	   and	   the	   freezing	   medium	   was	   neutralized	   in	   10%	   v/v	   FBS-­‐enriched	  (Fetal	  Bovine	  Serum;	  Invitrogen)	  IMDM.	  Cells	  were	  resuspended	  in	  MACS	  buffer	  (PBS;	  0.5%	  w/v	  BSA,	  Sigma-­‐Aldrich;	  2mM	  EDTA,	  VWR,	  Pennsylvania,	  USA)	  at	  a	  density	  of	  1	  x	  108	  cells/300	  μL	  and	  marked	  using	  a	  CD34	  MicroBead	  Kit	  (Myltenyi	  Biotec,	  Bergisch	  Gladbach,	   Germany).	   Succinctly,	  MNCs	  were	   incubated	   for	   30	  min	   at	   4ºC	  with	  magnetic	  CD34	  microbeads	   (microbeads	   conjugated	   to	  monoclonal	  mouse	   anti-­‐human	  CD34)	   and	  FcR	  blocking	  reagent	   (human	   IgG)	   to	  prevent	  non-­‐specific	  binding,	  using	  100	  μL	  of	  each	  solution	  for	  every	  108	  cells.	  After	  being	  washed	  with	  MACS	  buffer,	   the	   labeled	  cells	  were	  positively	  selected	  for	  CD34	  expression	  using	  the	  mini-­‐MACS	  immunomagnetic	  separation	  system	  (Myltenyi	  Biotec).	  The	  suspension	  was	  filtered	  through	  a	  30-­‐mm	  nylon	  mesh	  and	  loaded	  onto	  a	  column	  within	  a	  magnetic	  field.	  CD34+	  cells	  (bound	  to	  the	  CD34	  microbeads)	  were	  eluted	  after	   the	   column	  was	   removed	   from	   the	  magnet.	  The	   resulting	   cell	   solution	  was	   loaded	   onto	   a	   new	   column	   and	   the	   purification	   step	   was	   repeated.	   The	   final	   cell	  solution	  was	  submitted	  to	  several	  characterization	  assays:	  assessment	  of	  expression	  of	  EC	  markers	  using	   fluorescence-­‐activated	   cell	   sorting	   (FACS),	   detection	   and	   characterization	  of	   colony	   formation	   in	   methylcellulose	   and	   in	   vitro	   cell	   culturing	   towards	   ECs	  differentiation.	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1.3.	  FLUORESCENCE-­‐ACTIVATED	  CELL	  SORTING	  ANALYSIS	  	   CD34+	  cells	  suspension	  and	  suspensions	  of	  CD34-­‐	  cells	  (which	  resulted	  from	  negative	  selection	   in	   the	   first	   and	   second	   columns)	   were	   aliquoted	   (1.25-­‐2.0	   x	   105	   cells	   per	  condition),	  centrifuged	  and	  resuspended	  in	  FACS	  Buffer	  (PBS;	  0.5%	  w/v	  BSA;	  0.01%	  w/v	  Azide,	  Sigma-­‐Aldrich).	  Half	  of	  each	  suspension	  was	  incubated	  for	  30	  minutes	  at	  4ºC	  with	  isotype	   controls	   (Mouse	   IgG1	   FITC	   and	   Mouse	   IgG1	   R-­‐PE;	   Caltag	   Medsystems,	  Buckingham,	  UK)	  or	  antigen-­‐specific	  mouse	  anti-­‐human	  antibodies:	  CD31-­‐APC	  (Myltenyi	  Biotec),	  CD34-­‐FITC	  and	  CD38-­‐PE	  (both	  from	  Caltag	  Medsystems).	  In	  the	  first	  assays,	  dead	  cells	   were	   marked	   with	   PI	   (Propidium	   Iodide	   Staining	   Solution;	   BD	   Biosciences,	   USA,	  www.bdbiosciences.com)	  before	  washing	  with	  FACS	  buffer.	  However,	  after	  identifying	  this	  population	  in	  the	  FACS	  results,	  cell	  suspensions	  were	  just	  washed	  and	  fixed	  with	  1%	  w/v	  paraformaldehyde	   (PFA;	   Merck	   Millipore,	   Darmstadt,	   Germany).	   Markers	   expression	  analysis	  was	  carried	  out	  by	  three-­‐color	  flow	  cytometry	  on	  a	  FACSCalibur	  flow	  cytometer	  (BD	   Biosciences).	   Data	   analysis	   was	   made	   using	   FlowJo	   software.	   At	   least	   three	  experiments	  were	  tested	  for	  each	  sample.	  
1.4.	  METHYLCELLULOSE	  ASSAY	  FOR	  COLONY	  CHARACTERIZATION	  	   CD34+	  cells	  were	  resuspended	  in	  complete	  endothelial	  growth	  medium	  (EGM)	  and	  50	  ng/mL	   of	   VEGF	   –	   endothelial	   basal	   medium	   (EBM™-­‐2;	   Lonza,	   Gaithersburg,	   Maryland,	  USA);	  SingleQuots®	  growth	   factors	  (EGM™-­‐2	  SingleQuots;	  Lonza):	  Hydrocortisone,	  hFGF-­‐B,	  VEGF,	  IGF-­‐1,	  Ascorbic	  acid,	  hEGF,	  GA-­‐1000	  and	  Heparin;	  20%	  v/v	  FBS	  (Invitrogen);	  and	  1%	   v/v	   Penicillin/Streptomycin	   (Pen/Strep;	   PAA,	   New	   Jersey,	   USA).	   1	   x	   104	   cells	   were	  aliquoted	   from	   the	   cell	   suspension,	  mixed	  with	  methylcellulose-­‐based	   semi-­‐solid	   culture	  medium	   (MethoCult®H4230;	   StemCell	   Technologies	   Inc.,	   London,	   UK)	   and	   distributed	  among	  3	  wells	  of	  a	  4-­‐well	  plate.	  The	  4th	  well	  of	  each	  plate	  was	  filled	  with	  PBS	  to	  prevent	  dehydration	   and	   the	   plates	   were	   incubated	   for	   14	   days	   at	   37ºC	   in	   a	   humidified	  atmosphere	  with	  5%	  v/v	  CO2	  in	  air.	  Three	  types	  of	  colonies	  were	  identified	  and	  counted	  after	  the	  incubation	  period:	  CFU-­‐GM;	  BFU-­‐E,	  CFU-­‐GEMM.	  
1.5.	  DIFFERENTIATION	  OF	  CD34+	  CELLS	  INTO	  ECS	  	   Isolated	  CD34+	  cells	  were	  resuspended	  in	  EGM	  with	  50	  ng/mL	  of	  vascular	  endothelial	  growth	   factor	   (VEGF;	   Sigma-­‐Aldrich)	   and	   plated	   onto	   1%	   w/v	   gelatin-­‐coated	   48-­‐well	  plates,	  at	  a	  density	  of	  approximately	  1	  x	  105	  cells/well.	  Starting	  on	  the	  5th	  day	  of	  culture,	  every	  2	  days	  half	  of	  the	  medium	  was	  replaced	  and	  fresh	  VEGF	  was	  added.	  The	  cells	  were	  incubated	   for	   21	   days	   at	   37ºC	   in	   a	   humidified	   atmosphere	  with	   5%	   v/v	   CO2	   in	   air.	   The	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expression	  of	  EC	  markers	  and	  functionality	  and	  behavior	  of	  the	  cells	  were	  assessed	  after	  5	  and	  21	  days.	  
1.6.	  DETECTION	  OF	  EXPRESSION	  OF	  EC	  MARKERS	  	   Immunofluorescence	  staining	  was	  performed	  to	  assess	  the	  expression	  of	  EC	  markers.	  CD34+	  cells	  were	  fixed	  with	  4%	  v/v	  PFA	  for	  30	  minutes	  at	  room	  temperature,	  washed	  with	  PBS	  and	  permeabilized	  with	  0.2%	  v/v	  Triton	  X-­‐100	  (Sigma-­‐Aldrich)	  in	  PBS	  for	  10	  minutes.	  To	   maintain	   the	   cadherin’s	   morphology,	   the	   respective	   samples	   were	   incubated	   for	   10	  minutes	   in	   ammonium	   chloride	   (50	  mM	  NH4Cl,	   Sigma-­‐Aldrich)	   before	   permeabilization.	  After	  washing	  with	  PBS,	   the	  samples	  were	   incubated	   for	  1	  hour	  at	   room	  temperature	   in	  blocking	  solution	  (4%	  v/v	  FBS	  in	  1%	  w/v	  BSA	  in	  PBS)	  and	  incubated	  overnight	  at	  4ºC	  with	  the	   following	  primary	   anti-­‐human	  antibodies:	  monoclonal	  mouse	  CD31	   (PECAM1;	  Dako,	  Denmark)	  and	  VE-­‐cadherin	  (VE-­‐cad;	  Santa	  Cruz	  Biotechnology,	  Texas,	  USA)	  and	  polyclonal	  rabbit	  von	  Willebrand	  factor	  (vWF;	  Dako).	  Excess	  antibody	  was	  removed	  by	  washing	  with	  PBS	  and	  the	  secondary	  antibodies	  (AlexaFluor®	  594	  anti-­‐mouse	  and	  anti-­‐rabbit;	  both	  from	  Invitrogen)	   were	   incubated	   for	   1	   hour	   at	   room	   temperature.	   The	   nucleus	   of	   cells	   was	  stained	  with	  FluoroShield™	  containing	  4',6-­‐diamidino-­‐2-­‐phenylindole	  (FluoroShield™	  with	  DAPI;	  Sigma-­‐Aldrich).	  In	  each	  experiment,	  HUVECs	  (Passage	  6-­‐8)	  were	  used	  as	  a	  positive	  control,	   and	   HUVECs	   without	   any	   primary	   antibody	   staining	   were	   used	   as	   a	   negative	  control	  to	  validate	  the	  assay.	  Samples	  were	  visualized	  under	  a	  Zeiss	  inverted	  fluorescence	  microscope	  (IFM;	  Zeiss	  Axiovert	  200,	  Carl	  Zeiss	   International,	  Germany,	  www.zeiss.com)	  and	  the	  resulting	  images	  were	  processed	  using	  Fiji	  Imaging	  Software.	  	  
1.7.	  ASSESSMENT	  OF	  PHENOTYPE	  EXPRESSION	  	  	   Samples	   were	   incubated	   with	   10	   μg/mL	   of	   DiI-­‐labeled	   acetylated	   low-­‐density	  lipoprotein	   (DiI-­‐Ac-­‐LDL;	   Biomedical	   Technologies,	   Stoughton,	   USA)	   for	   2	   hours	   at	   37ºC	  and	  washed	  three	  times	  with	  EGM.	  The	  uptake	  of	  Ac-­‐LDL	  was	  visualized	  under	  an	  inverted	  fluorescence	  microscope.	  
1.8.	  IN	  VITRO	  TUBE	  FORMATION	  ON	  MATRIGEL	  PLATE	  	   CD34+	  cells	  in	  culture	  were	  trypsinized	  and	  resuspended	  at	  a	  concentration	  of	  6	  x	  104	  cells/mL	  of	  EGM.	  One	  well	  of	   a	  24-­‐well	   cell	   suspension	  plate	  was	   coated	  with	  0.3	  mL	  of	  Matrigel™	  (BD	  Biosciences)	  and	  incubated	  for	  30	  minutes	  at	  37	  ºC.	  1	  mL	  of	  cell	  suspension	  was	  seeded	  on	  top	  of	  the	  Matrigel	  and	  the	  plate	  was	  incubated	  for	  24	  hours	  at	  37ºC	  in	  a	  humidified	  atmosphere	  with	  5%	  v/v	  CO2	   in	   air.	   Cord	   formation	  was	  evaluated	  by	  phase	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contrast	  microscopy	  on	   a	  Zeiss	  microscope	   (IFM).	  HUVECs	   (Passage	  10)	  were	  used	   as	   a	  positive	  control.	  	  	  
2.	  IN	  VITRO	  STUDIES	  WITH	  3D	  CULTURES	  	  	  
2.1.	  CELL	  CULTURE	  CONDITIONS	  	  	   HUVECs	   and	   MSCs	   (Lonza)	   were	   routinely	   kept	   in	   culture	   at	   37ºC	   in	   a	   humidified	  atmosphere	  with	   5%	   v/v	   CO2	   in	   air.	  Media	  was	   changed	   every	   two	   days:	  HUVECs	  were	  cultured	   in	   complete	   M199	   (Sigma-­‐Aldrich)	   with	   10%	   v/v	   FBS,	   0.1	   mg/mL	   Heparin	  (Heparin	   Sodium	   Salt;	   Sigma-­‐Aldrich),	   1%	   v/v	   Pen/Strep.	   Endothelial	   Cell	   Growth	  Supplement	  (ECGS;	  BD	  Biosciences)	  at	  a	  concentration	  of	  3	  μL/mL	  was	  added	  every	  time	  the	  media	   was	   changed.	   MSCs	   were	   cultured	   in	   Dulbecco’s	   Modified	   Eagle	  medium	   (D-­‐MEM;	   Invitrogen)	  with	  10%	  FBS	  and	  1%	  P/S.	  Both	  HUVECs	   and	  MSCs	  were	   trypsinized	  when	  they	  reached	  confluence.	  For	  the	  following	  experiments,	  cells	  from	  passages	  6	  and	  7	  were	  used.	  Regarding	  CD34+	  cells,	  isolation	  was	  made	  according	  to	  the	  method	  described	  in	  Section	  1.2	  and	  there	  was	  no	  incubation	  period	  prior	  to	  cell	  embedment.	  In	  co-­‐cultures,	  either	  HUVECs	  or	  CD34+	  cells	   in	  suspension	  were	  mixed	  (1:1	  ratio)	  with	  MSCs.	   In	  all	  3D	  conditions,	  cells	  were	  maintained	  in	  EGM	  during	  the	  culturing	  period.	  
2.2.	  CELL	  INCORPORATION	  WITHIN	  RGD-­‐GRAFTED	  ALGINATE	  HYDROGEL	  MATRICES	  	   To	  achieve	  RGD-­‐grafted	  alginate	  hydrogel	  disks	  at	  a	   final	  concentration	  of	  1	  wt.%	  in	  polymer	  and	  100	  μM	  of	  RGD,	  a	  gel	  precursor	  solution	  of	  previously	  prepared	  and	  modified	  alginates	  (according	  to	  Bidarra’s	  protocol	  [31])	  was	  prepared	  at	  a	  concentration	  of	  2	  wt.%	  in	  polymer	  and	  200	  μM	  of	  RGD.	  To	  do	  so,	  high	  molecular	  weight	  (HMW)	  oxidized	  alginate	  with	  and	  without	  grafted	  RGD	  were	  mixed	  (6.9	  mg	  and	  8.1	  mg,	  respectively)	  with	  15	  mg	  of	  low	  molecular	  weight	  (LMW,	  15	  mg)	  oxidized	  alginate	  and	  dissolved	  in	  0.9	  wt.%	  sodium	  chloride	   (NaCl;	   Sigma-­‐Aldrich).	   The	   final	   alginate	   solution	  was	   filter-­‐sterilized	   (0.22	   μm	  filters)	   before	   use.	   The	   hydrogel’s	   concentration	   and	   composition	   was	   chosen	   so	   that	  entrapped	   cells	   could	   adhere	   to	   the	   hydrogel	   and	   still	   have	   the	   necessary	   mobility	   to	  rearrange	  and,	  when	  needed,	  migrate,	  as	  reported	  by	  Fonseca	  et	  al.	  [32]	  and	  Bidarra	  et	  al.	  [31].	  	  Three	  types	  of	  culture	  were	  tested	  in	  each	  3D	  experiment:	  a	  co-­‐culture	  of	  HUVECs	  or	  CD34+	   cells	  with	  MSCs	   (1:1	   ratio)	   and	  monocultures	  of	   each	   cell	   type	  alone	   (HUVECs	  or	  CD34+	  cells	  and	  MSCs).	  In	  each	  condition,	  each	  type	  of	  cells	  was	  entrapped	  at	  a	  density	  of	  approximately	  5	  x	  106	  cells/mL	  –	  therefore,	  the	  disks	  seeded	  with	  cells	  in	  co-­‐culture	  had	  a	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cellular	  density	  of	  approximately	  10	  x	  106	  cells/mL.	  MSCs	  suspended	  in	  serum-­‐free	  DMEM	  were	   labeled	  with	  CellTracker™	  Blue (Invitrogen)	  by	   incubation	  with	  15	  μL	  of	   the	  stock	  solution	   (prepared	   according	   to	   the	   manufacturer)	   during	   30	   minutes	   and	   then	   with	  complete	  DMEM	  for	  another	  30	  minutes.	  The	  alginate	   gel	  precursor	   solution	  and	   cells	  were	   aliquoted	   for	   each	   condition	  and	  the	  preparation	  of	   the	  disks	  was	   carried	  out	   in	   the	   following	  way	   (gently	  homogenizing	  the	  mixture	  at	  every	  step):	  the	  RGD-­‐alginate	  gel	  precursor	  was	  mixed	  with	  fresh	  solutions	  of	   calcium	   carbonate	   (CaCO3;	   Sigma-­‐Aldrich)	   and	   filter-­‐sterilized	   glucone	   delta-­‐lactone	  (GDL;	  Sigma-­‐Aldrich),	  both	  dissolved	  in	  NaCl,	  to	  trigger	  gelification.	  The	  CaCO3/GDL	  molar	  ratio	   was	   set	   at	   0.125,	   which	   leads	   to	   initial	   acidification	   of	   the	   medium	   but	   prevents	  deposition	  and	  crystallization	  of	  CaCO3	  [32].	  This	  mixture	  was	  then	  combined	  with	  one	  of	  the	  aliquoted	  cell	   suspensions	   (HUVECs	  or	  CD34+	  cells,	  MSCs,	  HUVECs	   in	  co-­‐culture	  with	  MSCs	   or	   CD34+	   cells	   in	   co-­‐culture	   with	   MSCs,	   all	   of	   them	   previously	   centrifuged	   and	  resuspended	  in	  NaCl)	  and	  17	  μL	  of	  the	  final	  mixture	  were	  pipetted	  into	  each	  well	  of	  a	  24-­‐well	   cell	   suspension	   plate.	   The	   cell-­‐laden	   hydrogel	  matrices	  were	   left	   to	   crosslink	   for	   1	  hour	  at	  37ºC	  before	  EGM	  was	  added.	  The	  medium	  was	  changed	  30	  minutes	  after	  (since	  it	  becomes	   acidic	   during	   gelification)	   and	   the	   constructs	   were	   incubated	   at	   37ºC	   in	   a	  humidified	  atmosphere	  with	  5%	  v/v	  CO2.	  Every	  condition	  had	  at	  least	  3	  replicates.	  
2.3.	  CHARACTERIZATION	  OF	  CELL	  CULTURES	  WITHIN	  ALGINATE	  DISKS	  	   Regarding	   cell	   culture	   within	   alginate	   disks,	   all	   three	   conditions	   were	   tested	  throughout	   3	   days	   and	   at	   3	   time-­‐points	   (2h,	   24h	   and	   72h).	   Two	   experiments	   were	  performed:	   one	   with	   HUVECs	   and	   one	   with	   CD34+	   cells.	   Characterization	   was	   made	  according	   to:	  metabolic	   activity,	   cell	   viability,	   uptake	   of	   Ac-­‐LDL	   and	   expression	   of	   actin	  and	   fibronectin.	   At	   every	   time	   point,	   photographs	   of	   the	   disks	   were	   taken	   using	   a	  stereoscopic	  microscope	  (Olympus	  SZX10).	  
2.4.	  METABOLIC	  ACTIVITY	  AND	  CELL	  VIABILITY	  	  	   The	  metabolic	  activity	  of	  entrapped	  cells	  in	  alginate	  matrices	  was	  measured	  2,	  24	  and	  72	   hours	   after	   encapsulation	   for	   HUVECs/MSCs	   and	   24	   and	   72	   hours	   for	   CD34+/MSCs.	  Resazurin	  (Resazurin	  Sodium	  Salt	  at	  0.1	  mg/mL;	  Sigma-­‐Aldrich)	  was	  diluted	  (20%	  v/v)	  in	  EGM	  and	  incubated	  with	  the	  disks	  for	  2	  hours	  at	  37ºC.	  A	  fluorometer	  (Synergy	  MX;	  Biotek,	  Winooski,	  US)	  was	  used	  to	  excite	  the	  samples	  at	  530	  nm	  and	  read	  the	  fluorescence	  at	  590	  nm.	  EGM	  with	  resazurin	  was	  used	  as	  a	  blank	  sample.	  Cell	  viability	  within	  alginate	  disks	  was	  determined	  with	  a	  Live/Dead	  assay.	  	  The	  disks	  were	   washed	   twice	   in	   Phenol	   Red-­‐free	   IMDM	   (IMDM,	   no	   Phenol	   Red;	   Invitrogen)	   and	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incubated	   for	  45	  minutes	  at	   room	   temperature	   (RT)	  with	  working	   solutions	  of	  2	  μg/mL	  calcein	   AM	   and	   2.5μg/mL	   ethidium	  homodimer	   (both	   from	   Invitrogen).	   Afterwards,	   the	  constructs	  were	  washed	  twice	  with	  Phenol	  Red-­‐free	   IMDM	  and	  visualized	  under	  a	   laser-­‐scanning	   microscope	   (CLSM,	   Leica	   TCS-­‐SP2	   AOBS;	   Leica	   Microsystems,	   Wetzlar,	  Germany).	  The	  resulting	  images	  were	  processed	  using	  Fiji	  Imaging	  Software.	  	  
2.5.	  CELL	  MORPHOLOGY	  AND	  FIBRONECTIN	  EXPRESSION	  	   Incorporation	  of	  DiI-­‐Ac-­‐LDL	  was	  used	  as	  a	  cell	  marker	  for	  HUVECs	  and	  an	  indicator	  of	  phenotype	  differences	  in	  CD34+	  cells,	  (as	  described	  in	  Section	  1.7.);	  The	  disks	  were	  fixed	  in	   4%	  PFA	   in	   TBS/CaCl2	   before	   visualization,	   and	   the	   24	   and	   72	   hours	   constructs	  were	  also	   incubated	  with	   phalloidin	   (Alexa	   Fluor®-­‐488	   Phalloidin;	   Invitrogen)	   for	   1	   hour,	   to	  label	  F-­‐actin	  filaments.	  Extracellular	   fibronectin	  was	  stained	  at	  24h	  and	  72h.	  3D	  constructs	  were	   fixed	  with	  4%	  v/v	  PFA	   in	  TBS/CaCl2	   for	  30	  minutes	   at	   room	   temperature,	  washed	  with	  TBS/CaCl2	  and	   permeabilized	   with	   0.2%	   v/v	   Triton	   X-­‐100	   (Sigma-­‐Aldrich)	   in	   TBS/CaCl2	   for	   10	  minutes.	   The	   samples	   were	   then	   incubated	   for	   20	   minutes	   at	   room	   temperature	   in	  blocking	  solution	  (1%	  w/v	  BSA	  in	  TBS/CaCl2)	  and	  left	  overnight	  at	  4ºC	  with	  mouse	  anti-­‐human	   fibronectin	   monoclonal	   antibody	   (DSHB,	   Yowa,	   USA).	   Excess	   antibody	   was	  removed	   by	   washing	   with	   TBS/CaCl2.	   The	   secondary	   antibody	   (AlexaFluor®	   594	   anti-­‐mouse)	   and	   phalloidin	   were	   incubated	   for	   1	   hour	   at	   room	   temperature.	   Samples	   were	  visualized	   under	   a	   CLSM	   and	   the	   resulting	   images	   were	   handled	   using	   Fiji	   Imaging	  Software.	  	  
2.6.	  IN	  VITRO	  MIGRATION	  ASSAY	  OF	  3D	  CULTURE	  	   HUVECs	  were	  incubated	  with	  15	  μL/mL	  of	  CellTracker™	  Green	  (Invitrogen)	  in	  serum	  free	  M199	  and	  washed	  with	  complete	  M199;	  MSCs	  were	  labeled	  with	  CellTracker™	  Blue,	  using	   IMDM,	   as	   previously	   described.	   HUVECs/MSCs-­‐laden	   soft	   RGD-­‐alginate	   hydrogel	  disks	   were	   prepared	   as	   described	   in	   Section	   2.2.;	   After	   the	   first	   crosslinking	   hour,	   2-­‐chamber	   slides	   Lab-­‐Teks®	   (Electron	  Microscopy	   Sciences,	   Hatfield,	   US)	  were	   filled	  with	  Matrigel™	  (150-­‐200	  μL/cm2)	  and	  the	  cell-­‐laden	  constructs	  were	  loaded	  onto	  the	  chambers	  5	   minutes	   after	   gelification	   had	   started	   (as	   represented	   in	   Figure	   S-­‐2,	   SD).	   After	   30	  minutes	  at	  37ºC,	  EGM	  was	  added	  to	  all	  chambers	  and	  the	  Lab-­‐Teks®	  were	   incubated	   for	  48h	  at	  37ºC	  in	  a	  humidified	  atmosphere	  with	  5%	  v/v	  CO2.	  Every	  condition	  had	  at	  least	  3	  replicates.	  Phase-­‐contrast	   micrographs	   were	   taken	   in	   an	   IFM	   after	   2,	   24	   and	   48	   hours	   of	  incubation.	  Data	  was	  analyzed	  using	  Fiji	  Imaging	  Software.	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3.	  IN	  VIVO	  STUDIES	  WITH	  3D	  CULTURES	  	  
3.1.	  MATRICES	  IMPLANTATION	  	   Soft	   RGD-­‐alginate	   hydrogel	   disks	   containing	   HUVECs	   and	   MSCs	   in	   mono	   and	   co-­‐culture	   (1:1)	  with	   no	   cellular	   staining	  were	   prepared	   as	   described	   in	   Section	   2.2.	   Two	  experiments	  with	  mono-­‐	   and	   co-­‐cultures	  were	   performed:	   one	   in	  which	   the	   disks	  were	  kept	  in	  culture	  for	  5	  days	  before	  testing,	  and	  another	  where	  the	  disks	  were	  placed	  on	  the	  CAM	  on	  the	  same	  day	  they	  were	  prepared.	  Each	  disc	  was	   implanted	  onto	   the	  CAM	  of	  10	  days-­‐old	  chick	  embryos	  and	  an	  O-­‐ring	  (5	  mm	  diameter)	  was	  put	  on	  top	  of	  it	  to	  prevent	  the	  disks	  from	  getting	  lost..	  EBM	  was	  added	  at	  the	  time	  of	  incubation	  and	  every	  day	  for	  3	  days	  to	  prevent	  dehydration.	  	  After	  3	  days,	  the	  embryos	  were	  fixed	  with	  4%	  w/v	  PFA	  in	  TBS/CaCl2.	  The	  CAM	  area	  surrounding	   the	  O-­‐ring	  was	   cut	   out	   and	   photographed	   using	   a	   stereoscopic	  microscope	  (Leica	  M205).	   The	   newly	   formed	   vessels	   around	   the	   constructs	   were	   counted	   from	   the	  CAM	  fragment	  and	  the	  average	  and	  standard	  deviation	  of	  each	  condition	  was	  calculated.	  The	  CAMs	  were	  then	  kept	  in	  PBS	  for	  further	  histological	  analysis.	  	  	  
4.	  STATISTICAL	  ANALYSIS	  	   When	  applicable,	  data	  was	  analyzed	  by	  t-­‐tests	  and	  Turkey’s	  multiple	  comparison	  tests	  and	  results	  were	  considered	  statistically	  different	  at	  p<0.05.	  Prism™	  Software	  was	  used	  to	  perform	  statistical	  analysis.	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AIM	  
	   The	  first	  experiments	  were	  performed	  in	  order	  to	  optimize	  the	  isolation	  of	  CD34+	  cells	  from	   umbilical	   cord	   blood	   (UCB).	   UCB-­‐derived	   CD34+	   cells	   were	   isolated	   from	   several	  donors	   and	   the	   isolated	   populations	   were	   characterized	   by	   flow	   cytometry.	   Also,	   the	  expression	  of	  different	  endothelial	  and	  progenitor	  cell	  markers	  was	  assessed	  before	  and	  after	  differentiation.	  	  Ultimately,	   the	   objective	   of	   this	   work	   was	   to	   obtain	   and	   characterize	   EPCs	   from	   a	  CD34-­‐enriched	   population,	   following	   a	   previously	   established	   protocol,	   where	   the	  isolation	  of	  CD34+	  cells	  from	  MNCs	  was	  reported	  to	  yield	  late	  EPCs.	  	  
RESULTS	  	  
1.	  ISOLATION	  OF	  CD34+	  CELLS	  	  	   	  The	   process	   of	   CD34+	   cells	   isolation	  was	   repeated	   using	   10	   different	   UCB	   samples	  from	  different	  donors.	  The	  overall	  efficiency	  of	  the	  isolation	  protocol	  was	  represented	  by	  the	  average	  number	  of	  cells	  obtained	  after	  each	  of	  its	  key	  steps:	  isolation	  of	  mononuclear	  cells	   (MNCs),	  defrosting	  MNCs	   (which	  are	   frozen	  after	   isolation),	   isolation	  of	  CD34+	  cells	  from	  MNCs	  and	  viability	  of	  CD34+	  cells	  measured	  by	   flow	  cytometry.	  The	  detailed	  values	  for	  each	  experiment	  are	  available	  in	  Supplementary	  Data	  (SD),	  Figure	  S-­‐1.	  The	  number	  of	   cells	   considerably	   decreased	   from	   step	   to	   step	   (Figure	   6),	   as	   the	   simple	   process	   of	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freezing	  and	  thawing	  isolated	  MNCs	  led	  to	  a	  loss	  of	  around	  36	  ±	  15%	  of	  the	  cells.	  Within	  each	  sample	  of	  MNCs,	  only	  0.66±0.32%	  was	  obtained	  after	  magnetic	  cell	  sorting	  for	  CD34	  marker;	   furthermore,	   according	   to	   flow	   cytometry	   results,	   69±21%	   of	   these	   cells	   was	  viable.	  
2.	  	  CHARACTERIZATION	  OF	  CD34+	  CELLS	  	   After	  magnetic	  cell	  sorting,	  three	  samples	  were	  aliquoted	  from	  each	  experiment:	  the	  negatively	   selected	   cell	   suspension	   from	   the	   first	   column	   (Negative	   1),	   the	   negatively	  selected	  cell	  suspension	  from	  the	  second	  column	  (Negative	  2),	  and	  the	  positively	  selected	  cells	   from	   the	   second	   column	   (Positive).	   Flow	   citometry	   analysis	   was	   performed	   using	  cells	  suspensions	   from	  four	  different	  experiments.	   In	  Table	   I,	   expression	  of	  CD31,	  CD34	  and	   CD38	   markers	   in	   percentage	   of	   live	   population	   is	   presented;	   each	   sample’s	   gated	  population	   and	   correlation	   scatters	   are	   presented	   in	   Figure	   7.	   Dead	   cells	   and	   cellular	  debris	  were	  excluded	  from	  the	  gated	  population	  by	  comparison	  with	  preliminary	  results	  in	  which	  cell	  suspensions	  were	  marked	  with	  PI	  –	  representative	  scatters	  are	  available	   in	  
SD,	  Figure	  S-­‐4;	  also,	  the	  expression	  of	  these	  markers	  by	  isotypes	  can	  be	  consulted	  in	  SD,	  
Figure	  S-­‐5.	  	  FACS	   analysis	   showed	   that	   the	   isolation	   of	   CD34+	   cells	   was	   successful,	   with	  84.97±14.97%	  of	   the	   cells	   in	   the	  Positive	   sample	   expressing	  CD34.	  Also,	   these	   cells	   had	  higher	  expression	  of	  CD31	  (97.81±1.72%).	  In	  fact,	  most	  of	  the	  CD34+	  cells	  in	  the	  positive	  samples	   were	   also	   CD31+,	   according	   to	   the	   percentage	   of	   CD34+CD31+	   cells	  (91.23±8.63%).	  Likewise,	   the	  percentage	  of	  CD34+CD38-­‐	  cells	  was	  higher	   in	  the	  Positive	  sample	  (19.58±18.98%).	  Neither	  Negative	  1	  nor	  Negative	  2	  samples	  had	  high	  expression	  of	  CD34,	  as	  expected,	  but	   they	  had	  high	  CD31	  expression.	  Accordingly	   to	   these	  data,	   the	  cell	  population	   in	   the	  Positive	  samples	  will	  be	  referred	   to	  as	   “CD34+	  cells”	   from	  now	  on,	  and	  the	  Negative	  2	  samples	  will	  be	  termed	  “CD34-­‐	  cells”.	  
Table	   II	   –	   FACS	   analysis	   of	   CD34,	  CD31	   and	   CD38	   expression.	  Negative	  1	  and	  Negative	  2	  are	   the	  negatively	  selected	  cell	  suspensions	   from	  the	   first	  and	  second	  MACS	  columns,	  respectively.	  Positive	  is	  the	   positively	   selected	   cell	   suspension	   from	   the	   second	   column	   –	   CD34	   marked	   cells.	   The	   displayed	  
values	  are	  averages	  of	  four	  experiments	  (n=4).	  Detailed	  values	  for	  each	  experiment	  are	  available	  in	  SD	  –	  
Table	  S-­‐I.	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The	  hematopoietic	   colony-­‐forming	   ability	   of	   CD34+	   cells	  was	   assessed	  by	   culture	   in	  methylcellulose-­‐based	   semi-­‐solid	   culture	   medium	   for	   14	   days.	   Three	   types	   of	   colonies	  were	  detected,	  in	  different	  numbers:	  BFU-­‐E	  (erythroid	  progenitors)	  colonies	  were	  the	  less	  prevalent	   ones	   (17.3±1.7),	   followed	   by	   CFU-­‐GEMM	   colonies	   (24.3±2.6),	   which	   are	   the	  most	  primitive	  type	  of	  colonies,	  and	  finally	  CFU-­‐GM	  (Granulocytes,	  Macrophages)	  colonies	  were	   predominant	   (58.3±4.3).	   The	   fact	   that	   CD34+	   cells	   yielded	   three	   different	   types	   of	  cultures	  suggests	  that	  they	  were	  multipotent	  progenitor	  cells.	  	  However,	  these	  results	  are	  
Figure	  7	  –	  FACS	  analysis	  scatter	  images.	  The	  first	  three	  images	  represent	  each	  sample's	  gated	  population	  (FSC-­‐H	  vs.	  SSC-­‐H).	  The	  second	  row	  scatters	  correlate	  the	  expression	  of	  CD34	  (FL1-­‐H)	  and	  CD38	  (FL2-­‐H)	  and	  the	   scatters	   in	   the	   last	   row	   correlate	   CD34	   expression	   with	   CD31	   expression	   (FL4-­‐H).	   These	   results	   are	  
representative	  of	  the	  four	  experiments	  performed.	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only	   preliminary	   since	   the	   experiment	   was	   not	   repeated	   in	   order	   to	   statistically	  distinguish	  the	  samples.	  	  After	  culturing	  CD34+	  cells	  in	  complete	  differentiation	  medium	  (EGM)	  for	  5	  days,	  their	  morphology	   was	   round,	   but	   some	   discrete	   colonies	   had	   formed	   (Figure	   8A).	   Still,	  undifferentiated	   CD34+	   cells	   did	   not	   organize	   into	   tubular-­‐like	   structures	   (Figure	   8B)	  when	  cultured	   in	  Matrigel.	   Immunohistochemistry	  stainings	  showed	  that	  CD31	  and	  vWF	  were	   poorly	   expressed	   (Figure	   8C-­‐D),	   and	   there	   was	   no	   expression	   of	   VE-­‐cadherin	  (Figure	  8E).	  Incorporation	  of	  Ac-­‐LDL	  was	  also	  quite	  low	  (Figure	  8F).	  	  After	   21	   days	   in	   EGM,	   discrete	   colonies	   had	   evolved	   into	   round	   cell	   clusters	   with	  spindle-­‐shaped	   cells	   at	   the	   periphery	   (Figure	   9A),	   and	   the	   remaining	   cells	   formed	   big	  aggregates	   of	   round	   cells	   (Figure	   S-­‐7,	   SD).	   Also,	   CD34+-­‐derived	   cells	   expressed	   EC-­‐like	  features	  like	  expression	  of	  CD31	  and	  VE-­‐cadherin,	  production	  of	  vWF	  and	  incorporation	  of	  Ac-­‐LDL	  (Figure	   9C-­‐F),	   even	   though	   they	  did	  not	  organize	   into	  a	   cell	  monolayer	  or	   form	  cord-­‐like	  structures	  in	  Matrigel	  (Figure	  9B).	  
	  
Figure	   8	   –	   CD34+	   cells	   morphology	   and	   phenotypic	   expression	   after	   5	   days	   in	   culture.	   A-­‐B:	   Phase	  contrast	   photomicrograph	  of	  A)	  CD34+	   cells	   in	   culture,	  with	  higher	  magnification	   inset;	  B)	   cells	   cultured	   in	  Matrigel	  for	  24h.	  Scale	  bar	  =	  150	  μm,	  50	  μm	  on	  the	  inset.	  C-­‐F:	  Expression	  of	  C)	  CD31,	  D)	  vWF,	  E)	  VE-­‐cadherin,	  and	  incorporation	  of	  F)	  Ac-­‐LDL.	  Scale	  bar	  =	  50	  μm.	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DISCUSSION	  	   Commonly,	   EPCs	   are	   defined	   as	   angiogenesis	   stimulating	   cells	  with	   endothelial	   cell	  features.	   Their	   angiogenic	   effect	   is	   a	   result	   of	   their	   ability	   to	   differentiate	   into	   mature	  endothelial	   cells	   and/or	   release	   paracrine	   stimuli,	   stimulating	   vessel	   formation	   and	  enhancing	  the	  formation	  of	  extracellular	  matrix.	  	  CD34+	  cells	  constitute	  an	  EPC-­‐rich	  population	  [14].	  These	  cells	  can	  be	  isolated	  either	  from	   peripheral	   or	   umbilical	   cord	   blood;	   however,	   they	   are	   assumed	   to	   be	   at	   a	   more	  primitive	  stage	  in	  the	  later	  [17],	  [38].	  Still,	  they	  are	  rare	  [22]	  and	  their	  isolation,	  although	  effective	   (84.97±14.79%	   of	   the	   positively	   marked	   cell	   population	   expressed	   CD34),	  involved	  significant	  cell	  losses	  (Figure	  6).	  	  First	   of	   all,	   the	   process	   of	   freezing	   and	   thawing	  MNCs	   caused	   cellular	   death,	   due	   to	   the	  presence	  of	  dimethyl	  sulfoxide	  (DMSO)	  in	  the	  freezing	  medium,	  which	  is	  a	  cryoprotectant	  but	   causes	   changes	   of	   osmolarity	   in	   cell	   suspensions,	   and	   also	   due	   to	   the	   abrupt	  temperature	  changes	  that	  might	  have	  caused	  lysis	  of	  the	  membrane	  of	  more	  fragile	  MNCs	  
Figure	  9	  –	  CD34+-­‐derived	  cells	  morphology	  and	  phenotypic	  expression	  after	  21	  days	   in	  culture.	  A-­‐B:	  Phase	   contrast	   photomicrograph	  of	  A)	  CD34+-­‐derived	   cells	   in	   culture;	  B)	   cells	   cultured	   in	  Matrigel	   for	   24h.	  
Scale	  bar	  =	  100	  μm.	  C-­‐F:	  Expression	  of	  C)	  CD31,	  D)	  vWF,	  E)	  VE-­‐cadherin,	  and	  incorporation	  of	  F)	  Ac-­‐LDL.	  Scale	  
bar	  =	  50	  μm.	  
VE-­‐cad	  Nuclei	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   Ac-­‐LDL	  
An	  endothelial	  cells-­‐delivery	  system	  for	  therapeutic	  angiogenesis.	  	  
	   40	  
or	   even	   other	   contaminating	   polymorphonuclear	   cells.	   Nevertheless,	   in	   these	   situations	  the	  percentage	  of	  CD34+	  cells	  increases,	  so	  the	  lost	  cells	  were	  not	  of	  great	  importance	  [39].	  	  Lower	  cellular	  viability	   in	   later	  experiments	  might	  have	  resulted	  from	  a	  higher	  period	  of	  time	   at	   -­‐80ºC,	   which	   could	   have	   irreversibly	   damaged	   the	   cell’s	   membranes.	   Also,	   the	  isolation	   process	   (explained	   in	   Materials	   and	   Methods,	   Section	   1)	   required	   great	  sensitivity	   from	   the	   user,	   especially	  when	  washing	   the	   columns	   (nearly	   all	   of	   the	   buffer	  should	  pass	  the	  column	  before	  more	  buffer	  was	  added	  to	  it,	  but	  the	  column	  could	  not	  dry)	  and	  eluting	  the	  CD34-­‐marked	  cells	  outside	  the	  magnetic	  field	  (the	  pressure	  applied	  to	  the	  column	   had	   to	   be	   controlled);	   therefore,	   the	   best	   results	   regarding	   the	   percentage	   of	  CD34+	  cells	  were	  obtained	  on	  later	  isolations,	  as	  depicted	  in	  Figure	  S-­‐3	  (SD).	  	  CD34	   and	   CD31	   are	   typically	   viewed	   as	   endothelial	   cell	   lineage	  markers;	   however,	  CD34	  marks	   only	   endothelial	   cells	   and	   stem	   cell	   progenitors,	   whereas	   CD31+	   cells	   can	  derive	   from	   the	   endothelial	   lineage	   or	   other	   types	   of	   MNCs	   (for	   more	   info,	   see	   [40]).	  Therefore,	   CD34+CD31+	   marked	   cells	   are	   hematopoietic-­‐lineage	   EPCs	   that	   express	  endothelial	  cell	  markers	  [21],	  [41].	  On	  the	  other	  hand,	  CD38	  is	  a	  cluster	  of	  differentiation	  that	  marks	   the	  majority	  of	  MNCs	   (lymphocytes,	  monocytes	  and	  macrophages),	   including	  stem	  cell	  precursors,	  but	   is	  not	  detected	   in	  endothelial	  cells	  –	  consequently,	  CD34+CD38-­‐	  cells	   are	   of	   an	   undifferentiated	   form	   –	  multipotent	   hematopoietic	   progenitor	   cells	   [24],	  [42].	   According	   to	   Table	   I,	   the	   population	   of	   positively	   selected	   cells	   was	   mainly	  composed	   of	   hematopoietic-­‐lineage	   EPCs	   (CD34+CD31+	   cells)	   and	   the	   amount	   of	  hematopoietic	   progenitor	   cells	   (CD34+CD38-­‐)	   varied	   a	   lot	   between	  donors,	   as	   the	  use	  of	  biological	   samples	   is	   always	   associated	   to	   high	   variability.	   Contamination	   with	  hematopoietic	  cells	  was	  also	  a	  risk	  –	  the	  percentage	  of	  CD31+	  cells	  was	  always	  higher	  than	  the	   percentage	   of	   CD34+	   cells.	   Luckily,	   most	   of	   these	   “contaminating”	   hematopoietic	  mononuclear	  cells	  were	  eluted	  in	  the	  first	  and	  second	  isolation	  columns	  (Negative	  1	  and	  2	  cell	   suspensions	   had	   high	   percentages	   of	   CD31+	   cells),	   reinforcing	   the	   utility	   and	  effectiveness	  of	  using	  two	  isolation	  columns.	  	  CD34+	   cells	   reorganized	   into	   three	   different	   types	   of	   hematopoietic	   colonies	   in	   the	  colony	  forming	  unit	  (CFU)	  assay;	  hence,	   their	  multipotency	  was	  confirmed.	  Also,	   the	   fact	  that	  CD34+	  cells	  produced	  higher	  numbers	  of	  CFU-­‐GM	  suggests	   that	  CD34+-­‐derived	  EPCs	  might	  ultimately	  be	  derived	  from	  hematopoietic	  cells	  like	  monocytes	  and	  macrophages,	  as	  proposed	  by	  Schmeisser	  et	  al.	  [43]	  and	  Rehman	  et	  al.	  [44].	  	  Even	   though	   the	   CD34+-­‐derived	   cells	   morphology	   did	   not	   resemble	   the	   EC-­‐like	  cobblestone	  appearance	  described	  by	  Ingram	  et	  al.	  [17]	  after	  21	  days,	  it	  was	  similar	  to	  the	  colony-­‐forming	  EPCs	  morphology	  that	  is	  characteristic	  of	  early	  EPCs	  (Figure	  4)	  [15].	  Also,	  the	  expression	  of	  EC	  markers	  and	   the	  uptake	  of	  Ac-­‐LDL	  were	  noticeably	   increased	   from	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day	   5	   to	   day	   21	   of	   culture.	   Even	   though	   no	   cell-­‐cell	   adherent	   junctions	   were	   detected,	  probably	  due	  to	  the	  absence	  of	  a	  confluent	  monolayer	  of	  cells,	  and	  the	  cells	  did	  not	  form	  tube-­‐like	   structures	   in	   Matrigel,	   it	   was	   clear	   that	   these	   cells	   underwent	   endothelial	  commitment	   throughout	   the	   21	   days	   of	   incubation	   [20],	   [43].	   Nonetheless,	   since	   no	  immunohistochemistry	   analysis	   was	   performed	   somewhere	   in	   the	   middle	   of	   the	  experiment	   (after	   10	   days,	   for	   example),	   it	   is	   hard	   to	   tell	   exactly	   how	   much	   time	   was	  needed	  for	  this	  commitment	  to	  occur.	  	  The	  protocol	  used	  was	  based	  on	  the	  protocol	  published	  by	  Pedroso	  et	  al.	   [20],	  since	  their	  aim	  was	  also	  to	  assess	  the	  pro-­‐angiogenic	  potential	  of	  CD34+	  and	  CD34+-­‐derived	  cells	  in	  3D	  cultures.	  However,	  our	  results	  differed:	   they	  claimed	  that	  UCB-­‐derived	  CD34+	  cells	  differentiated	   into	   late	   EPCs	   after	   21	   days;	   yet,	   the	   data	   here	   presented	   suggests	   UCB-­‐derived	   CD34+	   cells	   yielded	   a	   population	   of	   early	   EPCs,	  which	   did	   not	   differentiate	   into	  mature	   endothelial	   cells	   but	   might	   stimulate	   angiogenesis	   by	   secretion	   of	   paracrine	  factors.	  Nevertheless,	  these	  results	  are	  consistent	  with	  the	  general	  definition	  of	  early	  EPCs	  [14]	  [15].	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AIM	  	  The	  main	  aim	  of	  this	  part	  of	  the	  work	  was	  to	  create	  an	  ideal	  microenvironment	  for	  EC	  entrapment,	   based	   on	   an	   integrative	   approach	   combining	   an	   optimized	   hydrogel	  matrix	  with	  the	  use	  of	  MSCs	  as	  mural	  cells	  [23].	  Based	  on	  some	  of	  our	  group’s	  previous	  results,	  soft	  RGD-­‐grafted	  alginate	  hydrogels	  were	  used,	  as	  they	  have	  been	  shown	  to	  promote	  the	  self-­‐assembly	   of	   entrapped	   cells	   (both	   ECs	   [31]	   and	   MSCs	   [28],	   and	   the	   deposition	   of	  endogenous	   ECM	   by	   MSCs	   [28].	   Ideally,	   these	   matrices	   should	   assure	   cellular	   viability,	  support	   cell	   rearrangement	   and	   network	   formation,	   and	   also	   allow	   cells	   to	  migrate	   out	  from	  the	  matrices.	  Monocultures	  of	  HUVECs	  and	  MSCs	  and	  co-­‐cultures	  of	  both	  cell	   types	  (1:1)	   were	   established	   and	   characterized	   at	   different	   levels.	   Similar	   assays	   were	  performed	   using	   freshly	   isolated	   CD34+	   cells,	   as	   a	   preliminary	   assay	   to	   evaluate	   the	  behavior	   of	   these	   cells	   in	   3D	   culture.	  Due	   to	   time	   constraints,	   differentiated	  CD34+	   cells	  were	  not	  tested.	  	  	  
RESULTS:	  	  
1.	  HUVECS	  AND	  MSCS	  3D	  CULTURES	  
1.1	  METABOLIC	  ACTIVITY	  AND	  VIABILITY	  	  	   Upon	  entrapment,	   the	  metabolic	  activity	  of	  all	  matrices	  was	  measured	  (Figure	   10).	  Whilst	  MSCs	  alone	  and	   in	  co-­‐culture	  displayed	  some	  metabolic	  activity	   (1340	  ±	  305	  and	  2577	  ±	  573	  RFU,	  respectively),	  HUVECs	  lacked	  it,	  presenting	  similar	  activity	  values	  to	  the	  blank	  sample.	  On	  the	  other	  hand,	  after	  being	  entrapped	  for	  24	  hours,	  the	  three	  types	  of	  cell	  cultures	  presented	  higher	  metabolic	  activities	   (3405	  ±	  564,	  4753	  ±	  194	  and	  9662	  ±	  291	  RFU,	   respectively).	   After	   72	   hours,	   HUVECs/MSCs	   cultures	   maintained	   their	   activity	  (10200	   ±	   400	   RFU),	   whilst	   the	   activity	   of	   HUVECs	   and	   MSCs	   monocultures	   decreased	  slightly	  (2461	  ±	  1395	  and	  3490	  ±	  382	  RFU,	  respectively).	  	  After	   24	   hours	   in	   culture,	   all	   conditions	   had	   a	   few	   dead	   cells,	   as	   evaluated	   by	   the	  Live/Dead	  assay	  (Figure	  11),	  but	  HUVECs-­‐laden	  matrices	  were	  the	  ones	  with	  the	  lowest	  viability.	   Importantly,	   the	   overall	   survival	   of	   HUVEC	   appeared	   to	   be	   increased	   by	   the	  presence	   of	   MSCs.	   Also,	   while	   in	   monocultures	   live	   HUVECs	   and	   MSCs	   exhibited	   a	  predominantly	  round	  shape	  and	  were	  individually	  distributed	  along	  the	  matrix,	   live	  cells	  in	  co-­‐culture	  seemed	  to	  spread	  to	  some	  extent,	  and	  established	  contacts	  with	  other	  cells.	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1.2.	  CELL	  REARRANGEMENT	  AND	  MATRIX	  FORMATION	  IN	  HUVECs/MSCs	  3D	  CULTURES	  	   All	  of	  the	  hydrogel	  matrices	  suffered	  some	  cell-­‐driven	  reduction	  in	  their	  diameter,	  but	  this	   was	   specially	   observed	   co-­‐cultured	   constructs,	   which	   were	   reduced	   to	   almost	   half	  (54%)	  of	  their	  initial	  diameter	  after	  72	  hours	  in	  culture	  (Figure	  12).	  HUVECs	  and	  MSCs	  in	  monoculture	  caused	  minimal	  diminishment	  of	  the	  matrices	  diameter	  (86%	  and	  83%	  of	  the	  initial	  diameter,	  respectively),	  which	  kept	  a	  soft	  and	  fragile	  consistency	  at	  all	  times.	  	  	  In	   order	   to	  better	   analyze	   the	   relative	   spatial	   organization	  of	   both	   cell	   types	   in	   co-­‐culture,	  MSCs	  were	   pre-­‐labeled	  with	   CellTraker	   Blue	   before	   entrapment,	   while	   HUVECs	  were	   labeled	   by	   incorporation	   of	   DiI-­‐Ac-­‐LDL	   (red)	   at	   the	   end	   of	   the	   culture.	   Moreover,	  cytoskeleton	   re-­‐organization	   was	   analyzed	   by	   f-­‐actin	   staining	   with	   a	   fluorescent	   dye	  (green).	   Important	   differences	   were	   observed	   between	  monocultures	   (data	   not	   shown)	  and	  co-­‐cultures.	  As	  depicted	  in	  Figure	  13,	  HUVECs	  and	  MSCs	  in	  co-­‐culture	  reorganized	  so	  that	   instead	   of	   remaining	   round	   and	   isolated	   (2	   hours),	   they	   spread	   (24	   hours)	   and	  formed	  multi-­‐cellular	  networks	  of	  increasing	  complexity	  (24	  and	  72	  hours)	  (Figure	  12).	  	  
Figure	  11	  –	  Live/Dead	  Assay	  24	  hours	  after	  cell	  embedment.	  The	  percentage	  of	  dead	  cells	  was	  especially	  high	  in	  the	  monocultures.	  In	  co-­‐culture,	  live	  cells	  were	  stretched.	  Scale	  bar	  =	  100	  μm.	  One	  sample	  per	  condition	  
was	  analyzed,	  under	  confocal	  fluorescence	  microscope.	  
Live	  cells	  
Dead	  cells	   	  MSCs	  
Figure	   10	   –	   Metabolic	   activity	   of	   HUVECs/MSCs	   3D	   cultures	   throughout	   a	   3-­‐day	   culturing	   period.	  Metabolic	   activity	  was	   severely	   increased	   from	   day	   0	   (2	  hours)	   to	   day	   1	   (24	   hours)	   and	  maintained	   from	  thereon.	  All	  values	  are	  relative	  to	  blank	  sample	  (EGM).	  *	  means	  p	  is	  <0.05.	  
	  
*	  
In	  vitro	  studies	  with	  3D	  cultures.	  
	   47	  	  
Figure	  12	  –	  General	  appearance	  of	  alginate	  hydrogel	  disks	  2,	  24	  and	  72	  hours	  after	  cell	  embedment.	  All	   of	   the	   disks	   diameters	  were	   diminished;	   however,	   co-­‐cultured	   disks	   displayed	   drastic	   differences	   and	  formed	  dense	  aggregates.	  Photos	  were	  taken	  using	  a	  stereoscopic	  microscope;	  each	  cell	  culture	  is	  represented	  
by	  one	  disk,	  photographed	  at	  3	  different	  time-­‐points.	  	  
	  
Figure	  13	  –	  Morphology	  and	  spatial	  organization	  of	  HUVECs	  and	  MSCs	  in	  3D	  co-­‐culture.	  Both	  types	  of	  cells	  rearranged	   inside	   the	  matrix	  and	   started	  expressing	  F-­‐actin	  24	  hours	  after	   incubation.	  F-­‐actin	  microfilaments	  were	  detected	  after	  72	  hours.	  Some	  ECs	  were	  able	   to	  align	   into	   tubular-­‐like	  structures.	  Different	  samples	  were	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Expression	  of	  F-­‐actin	  was	  detected	  after	  24	  hours	  (apparently	  mostly	  by	  MSCs,	  taking	  into	   account	   the	   co-­‐localization	   of	   blue/green	   staining),	   and	   after	   72	   hours	   F-­‐actin	  microfilaments	  were	  clearly	  visible	  around	  MSCs	  and	  HUVECs.	  More	  importantly,	  the	  co-­‐culture	  microenvironment	  induced	  ECs	  to	  assemble	  into	  cord-­‐like	  structures	  (aligned	  ECs	  depicted	  in	  A	  and	  B	  insets),	  and	  permitted	  a	  close-­‐proximity	  of	  both	  cell	  types.	  The	  expression	  of	  fibronectin	  (FN)	  was	  also	  analyzed,	  as	  this	  ECM	  protein	  plays	  a	  key	  role	   in	   the	  promotion	  of	   cell-­‐matrix	   interactions	   and	   in	   the	   stabilization	  of	  multicellular	  structures	   [45].	   When	   seeded	   alone,	   HUVECs	   and	   MSCs	   did	   not	   reorganize	   into	   multi	  cellular	   structures,	   but	   some	  FN	   expression	  was	  detected	  mainly	   intracellularly	   (Figure	  
14).	   The	   expression	   of	   both	   FN	   and	   F-­‐actin	   increased	   from	  24	   to	   72	   hours.	   Conversely,	  after	   24	   hours	   in	   co-­‐culture,	   cells	   were	   predominantly	   spread,	   as	   supported	   by	   the	  presence	  of	  organized	  F-­‐actin	  microfilaments,	  and	  were	  able	  to	  assemble	  an	  extracellular	  FN-­‐matrix.	   Ultimately,	   after	   72	   hours	   (Figure	   15)	   cells	   in	   co-­‐culture	   formed	   a	  multicellular	  network,	  embedded	  in	  a	  FN	  mesh.	  
Figure	  15	  –Decomposed	   confocal	   fluorescent	  microscopy	  image	  of	  3D	  HUVECs/MSCs	  culture	  after	  72	  
hours.	  Scale	  bar=150	  μm.	  
Figure	  14	  –	   Extracellular	  matrix	  and	  multicellular	  networks	   in	  HUVECs/MSCs	   3D	   culture.	  No	  networks	  were	   detected	   in	   monocultures;	   however,	   MSCs	   produced	   higher	   amounts	   of	   FN.	   Co-­‐cultured	   cells	   formed	  multicellular	  networks	  and	  a	  fibronectin	  matrix.	  Different	  samples	  were	  stained	  at	  each	  time	  point;	  samples	  were	  
visualized	  under	  confocal	  fluorescence	  microscope.	  Scale	  bar=150	  μm.	  
F-­‐Actin	  	  Fibronectin	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1.3.	  OUTWARD	  CELL	  MIGRATION	  	  	   To	  evaluate	  the	  ability	  of	  entrapped	  cells	  to	  migrate	  out	  from	  the	  matrices,	  cell-­‐laden	  hydrogel	  discs	  were	  prepared	  and	   immediately	  embedded	   into	  a	   tissue	  mimic	   (Matrigel,	  
Figure	  S-­‐2,	   in	  SD).	  As	  depicted	  in	  (Figure	  16,	  days	  1	  and	  2),	  some	  HUVECs	  protruding	  from	  monoculture	   matrices	   were	   visible	   after	   1	   day	   of	   culture	   (orange	   arrows),	   which	  formed	  tubular-­‐like	  structures	  that	  invaded	  the	  Matrigel,	  but	  these	  were	  no	  longer	  present	  after	  2	  days	  of	  culture.	  On	  MSC	  monocultures	  only	  a	  few	  sprouting	  MSCs	  were	  found	  even	  after	   2	   days	   of	   culture.	   In	   co-­‐cultured	   discs,	   numerous	   migrating	   cells	   with	   spread	  
Figure	  16	  –	  Representative	  phase-­‐contrast	  micrographs	  of	  cell-­‐laden	  disks	  embedded	  in	  Matrigel.	  Cell	  migration	  and	  stretching	  was	  significantly	   increased	  when	  HUVECs	  and	  MSCs	  were	  co-­‐cultured,	  before	  and	  after	  a	   period	   in	  EGM.	  One	  representative	  sample	  is	  shown	  per	  type	  of	  culture.	  Samples	  were	  visualized	  under	  
inverted	  microscope.	  Scale	  bar=200	  μm.	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morphology	  were	   detected	   at	   the	   periphery	   of	   the	   alginate	   disc	   (yellow	   arrows),	  which	  increased	   from	   day	   1	   to	   day	   2.	   Unfortunately,	   although	   both	   MSCs	   and	   HUVECs	   were	  successfully	   labeled	  with	   CellTracker	   (Blue	   and	   Green,	   respectively)	   before	   entrapment	  
(as	   seen	   in	   Figure	   S-­‐7,	   in	   SD),	   it	   was	   not	   possible	   to	   differentiate	   them	   amongst	   the	  migrating	   cells	   population,	   as	   the	   sprouting	   structures	   could	   not	   be	   visualized	   by	  fluorescence	  microscopy.	  Also,	  the	  previously	  described	  matrix	  contraction	  (Section	  1.2)	  generated	   a	   gap	   between	   the	   discs	   periphery	   and	   Matrigel	   (dotted	   and	   dashed	   lines,	  respectively),	   especially	   in	   co-­‐cultured	   constructs	   causing,	   inclusively,	   some	   discs	   to	  detach	   from	   the	   Matrigel	   layer.	   Moreover,	   as	   time	   in	   cultured	   progressed,	   the	   Matrigel	  started	  to	  degrade.	  Altogether,	   these	  technical	  difficulties	  did	  not	  allow	  a	  more	  thorough	  interpretation	  of	  the	  obtained	  results.	  The	  same	  discs	  were	  then	  re-­‐cultured	  in	  EGM	  for	  an	  additional	   period	   of	   4	   days,	   to	   allow	   full	   disc	   contraction,	   before	   placing	   them	   again	   in	  Matrigel	   at	   Day	   6.	   	   Along	   the	   4-­‐days	   incubation	   period,	   the	   metabolic	   activity	   of	   the	  entrapped	   cells	   increased	   in	   all	   the	   culture	   conditions	   	   (Figure	   17).	   Effectively,	   some	  additional	  matrix	  contraction	  was	  observed	  after	  the	  4-­‐days	  period,	  not	  only	  in	  co-­‐cultures	  but	   also	   in	   MSC	   monocultures.	   After	   24	   hours	   (Day	   7)	   of	   re-­‐implantation	   in	   Matrigel	  
(Figure	  16),	  MSC	  at	  the	  periphery	  of	  alginate	  discs	  stretched	  out	  about	  400	  μm	  onto	  the	  interface	   of	   the	   disc	   with	   Matrigel	   (Figure	   16,	   Day	   7,	   blue	   arrows).	   However,	   these	  structures	  did	  not	  seem	  to	  invade	  the	  Matrigel	  layer	  and	  did	  not	  further	  developed	  after	  1	  more	   day	   in	   culture	   (Day	   8).	   In	   HUVECs	  monocultures,	   no	   cell	  migration	  was	   detected.	  Contrarily,	   in	   co-­‐cultures	   at	   Day	   7,	   numerous	   migrating	   cells	   were	   present	   at	   the	   disc	  periphery,	  and	   invaded	   the	  Matrigel	   layer.	  After	  48	  hours	   in	  Matrigel	   (Day	  8),	   the	  entire	  construct	  was	  surrounded	  by	  sprouting	  cells.	  	  	  
	  
Figure	   17	   –	   Metabolic	   activity	   of	   cell-­‐seeded	   alginate	   disks	   before	   and	   after	   culture	   in	   EGM.	   The	  metabolic	  activity	  of	  the	  three	  types	  of	  culture	  was	  increased	  when	  they	  were	  left	  in	  culture	  for	  4	  days.	  The	  
experiment	  was	  performed	  once,	  in	  triplicate	  for	  each	  condition.	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2.	  CD34+	  CELLS	  AND	  MSCS	  3D	  CULTURES	  
2.1.	  METABOLIC	  ACTIVITY	  AND	  VIABILITY	  	  	  Moving	   on	   to	   the	   characterization	   of	   CD34+	   cells	   in	   a	   3D	   environment,	   CD34+	   cells,	  MSCs,	   and	   their	   co-­‐culture	   (1:1	   ratio)	   were	   embedded	   in	   alginate	   hydrogel	   discs.	  According	  to	  their	  metabolic	  activity	  readings	  (Figure	  18),	  MSCs	  activity	  decreased	  with	  time	   (8832	  ±	  148,	  8740	  ±	  1621	  and	  3479	  RFU	   for	  2,	  24	  and	  72	  hours	   respectively)	  and	  CD34+	  cells	  did	  not	  exhibit	  metabolic	  activity	  at	  any	   time	  points	   (at	  2	  hours,	   the	  activity	  was	  250	  ±	  52	  RFU,	  which	  is	  nearly	  0).	  The	  activity	  in	  co-­‐cultures	  was	  smaller	  than	  in	  MSCs	  after	   2	   hours	   (5184	  ±	   363	  RFU),	   but	   it	   increased	   after	   24	  hours	   (8478	  ±	   205	  RFU)	   and	  decreased	  after	  48	  hours	  (6605	  ±	  278	  RFU).	  	  When	   CD34+	   cells	   and	   MSCs	   were	   cultured	   alone,	   they	   presented	   abnormally	   high	  numbers	   of	   dead	   cells	   after	   24	   hours	   (Figure	   19).	   Even	   though	   initially	   CD34+/MSCs	  constructs	  had	   the	  highest	  viability,	   it	  decreased	  significantly	  on	   the	   following	  48	  hours;	  however,	   based	   on	   their	   smaller	   size,	   it	   seems	  most	   of	   the	   dead	   cells	   in	   co-­‐culture	   are	  CD34+	  cells.	  	  	  	  
	  	   	  
Figure	  18	  –	  Metabolic	  activity	  of	  CD34+	  cells/MSCs	  3D	  cultures	   throughout	  a	  3-­‐day	   culturing	  period.	  The	  activity	  of	  co-­‐cultured	  cells	  increased	  from	  day	  0	  (2	  hours)	  to	  day	  1	  (24	  hours)	  and	  decreased	  afterwards.	  MSCs	   activity	   decreased	   with	   time,	   and	   CD34+	   cells	   activity	   was	   null	   or	   close	   to	   it	   at	   all	   time-­‐points.	   The	  
experiment	  was	  performed	  once,	  and	  the	  bars	  without	  standard	  deviation	  represent	  values	  obtained	  from	  1	  or	  2	  
samples	  only.	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2.2.	  CELL	  REARRANGEMENT	  AND	  MATRIX	  FORMATION	  IN	  CD34+	  CELLS/MSCs	  3D	  CULTURES	  	   	  Based	  on	  the	  low	  cell	  viability	  in	  monoculture	  constructs,	  the	  following	  assays	  were	  only	  performed	  on	  co-­‐cultured	  discs.	  When	  cultures	  were	  incubated	  with	  DiI-­‐Ac-­‐LDL	  after	  24	   hours,	   no	   evident	   differences	  were	   detected	   between	  marked	  MSCs	   and	  CD34+	   cells;	  there	  seemed	  to	  be	  a	  residual	  uptake	  of	  Ac-­‐LDL	  from	  all	  cells.	  After	  72	  hours,	  CD34+	  cells	  were	  distinguishable	  from	  MSCs	  through	  a	  much	  stronger	  staining	  and	  their	  smaller	  size	  
(Figure	   20).	   Still,	   no	   rearrangement	   or	   co-­‐localization	   of	   the	   two	   types	   of	   cells	   was	  detected	  at	  any	  time	  point.	  Expression	  of	  both	  F-­‐actin	  and	  FN	  was	  detected	  after	  24	  and	  72	  hours,	   and	   some	   cells	   spread	   and	   formed	   networks	   while	   other	   remained	   essentially	  round.	  Although	  it	  is	  not	  easy	  to	  distinguish	  between	  the	  two	  cell	  types,	  looking	  at	  the	  cell	  size	  and	  the	  pattern	  of	  F-­‐actin	  staining,	  it	  seems	  that	  the	  spread	  cells	  are	  mainly	  MSC.	  FN	  was	  detected	  at	  24	  hours,	  but	  FN	  fibrils	  were	  only	  detected	  at	  72	  hours	  and	   in	  very	   low	  amounts	  (white	  arrows)	  	  	  	   	  
Figure	  19	  –	  Live/Dead	  Assay	  –	  24	  and	  72	  hours	  after	  cell	  embedment.	  After	  24	  hours	  of	  incubation,	  a	  great	  fraction	  of	  monocultured	  cells	  were	  dead.	  The	  same	  remains	  true	  for	  co-­‐cultures	  after	  3	  days	  in	  culture,	  where	   most	   of	   the	   dead	   cells	   seem	   to	   be	   CD34+	   (smaller	   size).	   Scale	   =	   150	   μm.	   Different	   samples	   were	  
sacrificed	  at	  different	  time-­‐points,	  and	  visualized	  under	  confocal	  fluorescence	  microscope.	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DISCUSSION:	  	  	  
1.	  HUVECs/MSCs	  3D	  CONSTRUCTS:	  	   In	  this	  study,	  a	  previously	  optimized	  soft	  RGD-­‐grafted	  alginate	  hydrogel	  was	  studied	  as	   a	   3D	  matrix	   for	   the	   culture	   of	   ECs.	   The	   final	   goal	   is	   the	   development	   of	   a	   vehicle	   for	  therapeutic	   endothelial	   cell	   delivery	   and	   angiogenesis	   stimulation.	   In	   the	   past,	   HUVECs	  3D-­‐monocultures	  were	   already	   successfully	   established	   using	   this	   hydrogel	   formulation	  that,	  in	  contrast	  to	  non-­‐modified	  alginate	  hydrogels	  (without	  RGD),	  was	  shown	  to	  promote	  the	   internal	   formation	   of	  multicellular	   ECs	   networks	   and	   the	   outward	  migration	   of	   ECs	  into	   Matrigel,	   with	   tube-­‐like	   structures	   formation	   [31].	   On	   the	   other	   hand,	   the	   same	  
Figure	  20	  –	  Cell	  functionality,	  morphology	  and	  extracellular	  matrix	  production	  in	  CD34+	  cells/MSCs	  3D	  
culture.	  CD34+	  cells	  clearly	  incorporate	  Ac-­‐LDL	  after	  72	  hours	  in	  culture	  (inset).	  Extracellular	  actin	  fibers	  are	  detected	  after	  24	  hours,	  whilst	  fibronectin	  secretion	  is	  much	  lower.	  White	  arrows:	  FN	  fibrils.	  Different	  samples	  
were	  used	  at	  each	  time	  point	  and	  for	  each	  assay	  (Ac-­‐LDL	  uptake	  and	  fibronectin/actin	  staining).	  The	  constructs	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formulation	   was	   previously	   shown	   to	   promote	   the	   formation	   of	   MSCs	   networks,	   with	  endogenous	   ECM	   (FN-­‐rich)	   deposition	   [28].	   Therefore,	   in	   an	   attempt	   to	   create	   an	   ideal	  microenvironment	   for	   EC	   entrapment	   [46],	   here	   we	   decided	   to	   test	   an	   integrative	  approach	  combining	  this	  optimized	  hydrogel	  matrix	  with	  the	  use	  of	  co-­‐entrapped	  MSCs	  as	  mural	  cells.	  The	   selected	   cell	   density	   was	   5	   x	   106	   cells/mL	   of	   each	   cell	   type,	   yielding	   a	  concentration	  of	  about	  10	  x	  106	  cells/mL	  on	  the	  co-­‐cultured	  discs.	  After	  the	  first	  2	  hours	  post-­‐entrapment,	   all	   of	   the	   cultures	   seemed	   to	   be	   at	   a	   steady,	   adaptive	   state	   (especially	  HUVECs).	   The	   metabolic	   activity	   increased	   after	   24	   hours,	   and	   then	   remained	   nearly	  constant	   until	   the	   end	   of	   the	   culture.	   However,	   the	   metabolic	   activity	   in	   co-­‐cultures	  plateaued	   between	   day	   1	   and	   day	   3,	  whilst	  monocultures	   activity	   slightly	   decreased,	   so	  there	  seemed	  to	  be	  a	  beneficial	  effect	  of	  HUVECs	  and	  MSCs	  over	  each	  other,	  even	  though	  the	  relative	  contribution	  of	  each	  cell	  type	  could	  no	  be	  discriminated.	  In	  what	  concerns	  cell	  viability,	  HUVECs	  monocultures	  presented	  a	  significant	  percentage	  of	  dead	  cells,	  contrary	  to	   that	  observed	  by	  Bidarra	  et	   al.,	  who	  previously	   reported	   that	   the	  viability	  of	  HUVECs	  within	   these	  matrices	   gradually	   decreases	  with	   time,	   but	   remaining	   high	   (80%)	   after	   3	  days	   of	   culture	   [11].	   These	   discrepancies	   may	   be	   a	   consequence	   of	   the	   different	   cell	  densities	  that	  were	  used	  (5	  x	  106	  cells/mL	  vs.	  20	  x	  106	  cells/mL).	   	  Also,	  previous	  studies	  with	   MSCs	   entrapped	   within	   similar	   3D	   matrices	   reported	   more	   significant	   discs	  compaction	  after	  24	  hours	  (around	  48%)	  [28]	  that,	  again,	  might	  be	  due	  to	  the	  different	  cell	  densities	  used	  here	  and	  in	  that	  study	  (5	  x	  106	  cells/mL	  vs.	  8	  x	  106	  cells/mL).	  Cell	   rearrangement	   into	   networks	   and	   deposition	   of	   FN-­‐rich	   ECM	   in	   co-­‐cultured	  constructs	  confirmed	  that	  cells	  were	  able	   to	  adhere	   to	   the	  polymeric	  matrix,	   spread	  and	  establish	  cell-­‐cell	  contacts.	  Even	  though	  HUVECs	  were	  not	   labeled	   in	  these	  assays,	   the	  F-­‐actin	  and	  FN	  network	  layouts	  suggest	  they	  were	  also	  involved	  in	  these	  structures.	  The	  fact	  that	  cellular	  networks	  were	  not	  detected	  in	  HUVECs	  or	  MSCs	  monocultures,	  even	  though	  they	   were	   at	   the	   same	   individual	   cell	   density	   in	   the	   co-­‐culture	   and	   were	   able	   to	   form	  cellular	  networks	  in	  other	  experiments	  [28],	  [31],	  highlights	  the	  importance	  of	  cell	  density	  optimization.	  Also,	  the	  culture	  medium	  we	  used	  could	  be	  optimized,	  not	  only	  by	  adjusting	  the	  growth	  factors	  used,	  but	  also	  by	  testing	  other	  media,	  like	  MSCGM,	  which	  was	  used	  by	  Maia	   et	   al.	   on	   the	   assays	  with	  MSCs	   [28].	  Nevertheless,	   in	   co-­‐cultures	   cells	  were	   able	   to	  connect	  and	  assemble	  a	  FN	  mesh,	  which	  appears	  to	  be	  a	  quite	  interesting	  feature	  as	  it	  has	  been	   established	   that	   FN	   fibrillogenesis	   regulates	   3D	   neovessel	   formation,	   namely	   by	  serving	  as	  a	  structural	  scaffolding	  that	  displays	  adhesive	  ligands	  on	  an	  mechanically	  ideal	  substratum	  [47].	  Also,	   the	  close-­‐proximity	  of	   the	  two	  cells	   types	   in	  co-­‐culture	   is	   likely	  to	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foster	   their	   interaction,	  which	   is	   also	   essential	   if	  MSCs	   are	   aimed	   to	   act	   as	   pericyte-­‐like	  supporting	  cells	  [27],	  [48],	  [49].	  	  Overall,	  as	  suggested	  by	  Maia	  et	  al.	  [28],	  when	  cells	  were	  entrapped	  within	  very	  soft	  alginate	   hydrogels	   they	   seemed	   to	   be	   able	   to	   rapidly	  modify	   their	   local	  mechanical	   and	  biochemical	   environment,	   become	   embedded	   and	   ultimately	   reside	   within	   a	   self-­‐synthesized	  ECM.	  	  Culturing	  the	  disks	  in	  EGM	  before	  repeating	  the	  migration	  assay	  led	  more	  cells	  from	  the	  co-­‐culture	  to	  migrate	  once	  they	  were	  in	  Matrigel.	  Even	  though	  the	  detected	  migrating	  sprouts	  were	  similar	  to	  MSCs	  sprouts,	  the	  fact	  that	  cellular	  migration	  was	  only	  relevant	  on	  HUVECs/MSCs	  constructs	  emphasizes	  the	  importance	  of	  co-­‐cultures.	  Also,	  HUVECs	  loss	  of	  ability	  to	   form	  networks	  (hence,	  spread)	  after	  a	   few	  days	   in	  culture	  had	  been	  previously	  reported	  by	  Moon	  et	  al.,	  in	  PEG	  hydrogels	  [50].	  The	  fact	  that	  co-­‐culture	  loaded	  constructs	  had	   higher	   sprout	   formation	   after	   a	   period	   in	   culture	   suggests	   that	   there	   might	   be	  advantages	   in	   pre-­‐culturing	   the	   cell-­‐laden	   constructs	   before	   implanting	   them	   in	   vivo,	   as	  the	  presence	  of	  a	  mature	  network	  within	  the	  construct	  can	  potentially	  yield	  better	  results	  [7].	  	  
2.	  CD34+	  CELLS/MSCS	  3D	  CULTURE	  	  As	  previously	  described,	  similar	  assays	  were	  performed	  using	  freshly	  isolated	  CD34+	  cells,	   as	   a	   preliminary	   assay	   to	   evaluate	   the	   behavior	   of	   these	   cells	   in	   3D	   culture.	   Cells	  were	  assayed	  not	  only	   in	  monoculture,	  but	  also	  co-­‐cultured	  with	  MSC,	  as	   these	  cells	  not	  only	   play	   an	   important	   role	   in	   angiogenesis,	   but	   also	   improve	   the	   expansion	   of	  hematopoietic	   stem	  cells	   and	  CD34+	  progenitor	   cells	   [51].	  When	  embedded	   in	   soft	  RGD-­‐alginate	  matrices,	  CD34+	  cells	  presented	  a	  nearly	  null	  metabolic	  activity	  at	  all	  times.	  This	  behavior	  had	  already	  been	  reported	  by	  Chen	  et	  al.	  [48],	  who	  cultured	  EPCs	  on	  a	  different	  polymer	  and	  concluded	  that	  those	  cells	  did	  not	  proliferate	  and	  also	  lost	  viability	  with	  time.	  However,	   from	  day	  1	   to	  day	  3,	   the	  metabolic	  activity	  of	  co-­‐cultures	  decreased	  much	   less	  than	  that	  of	  MSCs	  monocultures,	  suggesting	   that	   the	  co-­‐culture	  has	  a	  beneficial	  effect	  on	  one	  (or	  the	  two)	  cell	  types.	  Otherwise	  the	  behavior	  of	  the	  co-­‐cultured	  constructs	  would	  be	  similar	  to	  the	  MSCs.	  For	  example,	  CD34+	  cells	  proliferation	  might	  eventually	  be	  increased	  when	   these	   were	   co-­‐cultured	   with	   MSCs,	   as	   described	   by	   Walenda	   et	   al.[24].	   F-­‐actin	  networks	  seemed	  smaller	  but	  more	  organized	  after	  72	  hours	  than	  after	  24	  hours.	  Chen	  et	  al.	  had	  previously	  reported	  that	  the	  presence	  of	  ECFCs	  (late	  EPCs)	  diminished	  the	  extent	  of	  MSCs	   spreading	   and	   their	   proliferation	   [48].	   Another	   interesting	   feature	  was	   that,	   even	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though	  the	  constructs	  viability	  was	  low,	  co-­‐cultured	  CD34+	  cells	  started	  to	  incorporate	  Ac-­‐LDL	   after	   72	   hours	   in	   culture,	   what	   suggests	   that	   they	   did	   not	   completely	   lose	   their	  functionality,	   and	   eventually	   started	   to	   acquire	   an	   endothelial-­‐like	   phenotype	   [4].	  When	  compared	  to	  HUVECs,	  CD34+	  cells	  seemed	  to	  be	  more	  “dependent”,	  in	  the	  way	  that	  most	  of	  the	   times	   they	   need	   other	   type	   of	   cells	   to	   support	   their	   function	   and/or	   stimulate	   their	  differentiation	  [20],	  [23].	  These	  assumptions	  are	  obviously	  quite	  speculative	  and	  it	  would	  be	   important	   to	   repeat	   these	   experiments	   in	   future	   studies,	   using	   more	   biological	  replicates,	  to	  draw	  more	  valid	  conclusions.	  	  	  	  
	  In	  vivo	  studies	  with	  3D	  cultures	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AIM:	  	  The	  aim	  of	  this	  part	  of	  the	  work	  was	  to	  make	  a	  preliminary	  evaluation	  of	  the	   in	  vivo	  angiogenic	  potential	  of	  cell-­‐laden	  soft	  RGD-­‐alginate.	  Specific	  targets	  were	  to:	  (1)	  compare	  the	  effect	  of	  3D	  co-­‐cultures	  vs.	  monocultures;	  and	  (2)	  evaluate	  whether	  a	  pre-­‐culture	  time	  improves	   the	   system’s	   performance.	   The	   chorioallantic	   membrane	   (CAM)	   assay	   was	  chosen	  as	  the	  in	  vivo	  model	  due	  to	  its	  previously	  described	  advantages,	  and	  because	  it	  has	  been	   previously	   used	   to	   assess	   the	   efficiency	   of	   other	   cell-­‐laden	   hydrogels	   in	   inducing	  capillary	   formation	   [37].	  This	   study	  will	   function	  as	  a	  bridge	  between	  3D	   in	  vitro	   assays	  and	   in	  vivo	  mammalian	  models	  [36].	  Here,	  differences	  between	  HUVECs/MSCs	  3D	  mono-­‐	  and	   co-­‐cultures	   (1:1)	   in	   soft	   RGD-­‐alginate	   hydrogel	   matrices	   were	   assessed,	   with	   and	  without	  a	  5-­‐day	  pre-­‐culturing	  period.	  	  	  	  
RESULTS:	  	  Cell-­‐laden	  3D	  matrices	  prepared	  on	   the	  same	  day	  as	   the	   implantation	  and	  5	  days	  before	  (kept	   in	   EGM)	  were	   tested.	   Pre-­‐cultured	  HUVECs	  monocultures	  were	   not	   tested,	   due	   to	  technical	   problems.	   As	   previously	   described,	   matrices	   with	   co-­‐cultures	   and	   MSC	  monocultures	  suffered	  contraction	  throughout	  those	  5	  days	   in	  culture,	  which	  resulted	   in	  denser	  disks	  upon	  implantation.	  After	  3	  days,	  the	  CAM	  was	  fixed	  with	  PFA	  and	  the	  part	  of	  the	  membrane	   containing	   the	   scaffold	  was	   photographed,	   with	   and	  without	   the	   O-­‐ring.	  One	  of	   the	  embryos	   (with	  a	   co-­‐cultured	  construct)	  died.	  From	   their	  gross	  evaluation,	   all	  samples	   seemed	   to	   be	   incorporated	   into	   the	   CAM	   quite	  well	   and	   capillary	   vessels	   grew	  towards	  and	  underneath	  all	  disks	  (Figure	  21).	  New	  capillary	  vessels	  that	  were	  stimulated	  by	   the	   presence	   of	   the	   constructs	   were	   identified	   as	   zigzag	   vessels,	   sprouting	   from	   the	  parent	   vessel	   and	   directed	   towards	   the	   disk,	   changing	   th	   	   eir	   ordinary	   growth	   pathway	  
(Figure	   22).	   This	   step	   is	   the	   first	   and	   determinant	   step	   in	   angiogenesis	   stimulation,	   so	  these	  are	  the	  vessels	  that	  represent	  the	  construct’s	  influence	  on	  the	  CAM.	  Surprisingly,	  no	  differences	   were	   detected	   between	   the	   different	   culture	   types,	   but	   the	   angiogenesis	  stimulation	  seemed	   to	  be	   improved	   in	  pre-­‐cultured	  disks.	  Unfortunately,	   the	  experiment	  was	   only	   repeated	   once	   and	   the	   number	   of	   samples	  was	   not	   enough	   to	   yield	   a	   definite	  conclusion	  (only	  MSCs	  with	  and	  without	  previous	  culturing	  time	  had	  statistically	  different	  numbers	  of	  vessels	  formed).	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Figure	   21	   –	   Effect	   of	   different	   cell	   cultures	   and	   pre-­‐incubation	   of	   alginate	   hydrogel	   disks	   on	   blood	  
vessel	   density	   in	   CAM	   assay	   without	   VEGF.	   Even	   though	   the	   number	   of	   formed	   vessels	   seemed	   to	   be	  increased	  on	  constructs	  previously	  cultured,	  a	  significant	  difference	  was	  noticed	  in	  MSCs	  only	  (p<	  0.03)	  due	  to	  the	   small	   number	   of	   samples	   (n=4	   for	   MSCs	   0	   days	   and	   n=5	   on	   all	   other	   conditions).	   No	   difference	   was	  detected	   amongst	   different	   types	   of	   cells.	   The	   data	   shown	   are	   mean	   ±	   SD.	   *	   means	   statistically	   different	  
(p<0.05).	  	  
Figure	  22	  –	  Photograph	  of	  representative	  CAM	  of	  13	  day-­‐old	  chick	  embryo	  (Day	  3	  after	  implantation).	  The	  O-­‐ring	  (5	  mm	  diameter)	  kept	  the	  disks	  in	  place	  and	  facilitated	  the	  visualization	  of	  vasculature	  around	  it.	  
Samples	  were	  photographed	  under	  a	  stereoscopic	  microscope	  with	  2x	  amplification.	  Black	  arrows	  indicate	  new	  
capillary	  vessels	  in	  pre-­‐cultured	  MSCs-­‐laden	  disks,	  dotted	  line	  surrounds	  the	  disc.	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5.3.	  DISCUSSION:	  	   A	  CAM	  assay	  with	  alginate	  disks	  containing	  HUVECs,	  MSCs	  and	   their	  3D	  co-­‐cultures	  was	  performed	  in	  order	  to	  assess	  their	  efficiency	  in	   inducing	  capillary	  formation	  in	  vivo.	  Pre-­‐cultured	   (5	   days)	   and	   fresh	   constructs	   were	   implanted	   to	   detect	   if	   there	   is	   an	  advantage	   in	   implanting	   constructs	   with	   a	   mature	   network	   of	   cells	   and	   extracellular	  proteins,	   as	   previously	   described	   by	   others	   [7].	   While	   all	   of	   the	   samples	   stimulated	  capillary	   formation,	   even	   in	   the	   absence	   of	   exogenous	   VEGF	   supplementation,	   no	  differences	  were	  found	  between	  the	  different	  types	  of	  cultures.	  In	  the	  future,	  it	  would	  be	  important	  to	  increase	  the	  implantation	  time,	  and	  also	  run	  a	  control	  of	  acellular	  soft	  RGD-­‐grafted	  alginate	  hydrogels	   to	  see	   if	   the	  matrix	  has	  any	  bioactive	  effect	  by	   itself.	  Actually,	  there	   seemed	   to	   be	   an	   increased	   stimulation	   in	   all	   samples	   that	   were	   pre-­‐cultured,	  suggesting	  it	  might	  be	  advantageous	  to	  implant	  more	  mature	  cellular	  structures.	  However,	   these	  results	  were	  only	  preliminary	  and	  the	  experiment	  would	  have	  to	  be	  repeated	  in	  order	  to	  validate	  these	  conclusions	  and	  give	  them	  a	  statistical	  meaning.	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   Towards	  the	  development	  of	  a	  pro-­‐angiogenic	  cells-­‐delivery	  vehicle,	  the	  main	  aim	  of	  this	  work	  was	  to	  create	  an	  ideal	  microenvironment	  for	  EC	  entrapment	  using	  an	  integrative	  approach,	  combining	  an	  optimized	  hydrogel	  matrix	  with	  the	  use	  of	  co-­‐entrapped	  MSCs	  as	  mural	  cells.	  Regarding	   UCB-­‐derived	   CD34+	   cells,	   these	   cells	   seemed	   to	   differentiate	   into	   early	  EPCs,	   which	   present	   a	   different	   phenotype	   from	   mature	   endothelial	   cells.	   However,	  according	  to	  what	  is	  already	  known	  about	  EPCs,	  these	  cells	  might	  stimulate	  angiogenesis	  by	  secretion	  of	  paracrine	  factors.	   In	  the	  future	  it	  would	  be	  interesting	  to	  test	  CD34+	  cells	  and	  CD34+-­‐derived	  EPCs	  conditioned	  media	   in	   terms	  of	   their	  ability	   to	  stimulate	   tubule-­‐formation	   by	  HUVECs	   in	   a	  Matrigel	   assay.	   It	  would	   also	   be	   enlightening	   to	   evaluate	   the	  markers	  expression	  by	  flow	  cytometry	  not	  only	  using	  more	  markers,	  like	  AC133	  that	  is	  not	  expressed	  in	  mature	  ECs	  [52],	  but	  also	  in	  CD34+-­‐derived	  EPCs.	  This	   study	   suggests	   that	   the	   combination	   of	   soft	   RGD-­‐alginate	   matrices	   with	   co-­‐entrapped	   MSC	   might	   in	   fact	   be	   a	   suitable	   strategy	   to	   create	   an	   adequate	   3D	  microenvironment	  for	  ECs.	  If	  seeded	  with	  the	  right	  cell	  types	  at	  optimized	  densities,	  these	  hydrogels	  can	  not	  only	  support	  cells	  metabolic	  activity	  and	  viability,	  but	  also	  promote	  cell-­‐cell	   interactions	   and	   formation	  of	  multicellular	  networks	   stabilized	  by	   an	  organized	  FN-­‐rich	   extracellular	   matrix.	   These	   constructs	   also	   allowed	   the	   outward	   migration	   of	  embedded	  cells	  and	  cell	  sprouting	  through	  a	  tissue	  mimic,	  which	  is	  a	  key	  feature	  of	  a	  cell	  delivery	  system.	  The	  relevance	  of	  co-­‐culturing	  CD34+	  cells	  with	  MSCs	  was	  also	  confirmed	  as	  both	  seemed	  to	  exert	  some	  influence	  over	  each	  other.	  However,	  before	  more	  studies	  are	  performed,	   it	  would	  be	  important	  to	  optimize	  the	  culturing	  conditions	  for	  this	  particular	  cell	  type,	  namely	  in	  terms	  of	  matrix	  formulation.	  In	   the	   future,	   it	   will	   be	   crucial	   to	   repeat	   these	   3D	   assays	   and	   further	   optimize	   the	  culturing	   conditions,	   specifically	   regarding	   cell	   density.	   For	   example,	   it	   would	   be	  interesting	  to	  incorporate	  the	  same	  number	  of	  cells	  in	  all	  samples,	  regardless	  of	  the	  type	  of	  cell	   culture.	   Leaving	   the	   samples	   for	   a	   longer	   period	   of	   time	   in	   culture	   could	   also	   yield	  more	   answers	   regarding	   their	   progressive	   reorganization.	   Also,	   MSCs	   could	   be	   labeled	  with	  pericyte	  markers	  like	  smooth	  muscle	  myosin,	  in	  order	  to	  evaluate	  if	  they	  effectively	  acquire	  a	  pericyte-­‐like	  phenotype	  and	  start	  lining	  the	  ECs	  tubular	  structures.	  Conclusively,	  it	   might	   be	   interesting	   to	   evaluate	   the	   potentially	   synergistic	   effect	   of	   co-­‐delivering	  specific	   growth	   factors	   [34]	   or	   performing	   tri-­‐cultures	   of	   mature	   ECs	   with	   EPCs	   and	  supporting	  cells,	  like	  MSCs.	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Red	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Figure	  S-­‐1:	  	  Location	  of	  the	  ring	  formed	  by	  MNCs.	  (Adapted	  from	  www.stemcell.com)	  
	  
Figure	  S-­‐2:	  Representation	  of	  a	  3D	  culture	  migration	  assay.	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  Table	   S-­‐III	   –	   FACS	   analysis	   of	   CD34,	   CD31	   and	   CD38	   expression	   in	   each	   sample.	   Each	  experiment	   derived	   from	   a	   different	   umbilical	   cord	   blood	   sample.	   Values	   are	   expressed	   in	  percentage	  of	  the	  overall	  gated	  population	  (live	  cells).	  Negative	  1	  and	  Negative	  2	  are	  the	   flow	  through	  suspensions	  from	  the	  first	  and	  second	  MACS	  columns,	  respectively.	  Positive	  is	  the	  flow	  through	  from	  the	  second	  column,	  outside	  the	  magnetic	  field	  –	  CD34	  positively	  marked	  cells.	  
EXP. 6 EXP. 8 EXP. 9 EXP. 10 Average Std. Dev.
% viable cells 60.40 92.00 79.80 67.50 74.93 12.06
% CD34+ cells 1.28 0.12 0.42 0.03 0.46 0.49
% CD31+ cells 60.68 85.02 85.41 81.86 78.24 10.23
% CD34+CD38- cells 0.00 0.00 0.00 0.00 0.00 0.00
% CD34+CD31+ cells 4.25 15.06 20.66 25.89 16.46 8.03
% viable cells 75.30 77.00 77.40 75.50 76.30 0.91
% CD34+ cells 25.56 6.13 0.08 2.95 8.68 9.98
% CD31+ cells 73.95 85.37 83.54 86.10 82.24 4.88
% CD34+CD38- cells 2.15 0.60 0.47 0.00 0.81 0.93
% CD34+CD31+ cells 43.70 25.85 24.36 8.81 25.68 12.36
% viable cells 87.20 62.30 82.80 42.60 68.73 17.77
% CD34+ cells 98.29 94.58 60.42 86.60 84.97 14.79
% CD31+ cells 98.69 98.43 94.88 99.26 97.81 1.72
% CD34+CD38- cells 6.52 0.64 21.46 49.71 19.58 18.98
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Figure	   S-­‐5	   -­‐	   FACS	   scatter	   images	   of	   isotype.	   The	   first	   three	   images	   represent	   each	   sample's	  gated	  population	  (FSC-­‐H	  vs.	  SSC-­‐H).	  The	  second	  row	  displays	  the	  scatters	  for	  expression	  of	  CD34	  (FL1-­‐H)	  versus	  CD38	   (FL2-­‐H)	  and	   the	   last	   row	  has	   the	   scatters	   for	  CD34	  versus	  CD31	   (FL4-­‐H).	  These	  are	  images	  from	  EXP.8,	  but	  are	  representative	  of	  the	  four	  experiments	  that	  were	  analyzed.	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Figure	  S-­‐6	  –	  Analysis	  of	  protein	  expression	  in	  HUVECs	  using	  immunohistochemistry.	   	  A,	  B,	  C)	  Immunofluorescence	  protein	  expression	  results:	  CD31,	  vWF	  and	  VE-­‐cadherin	  (Scale	  bar	  =	  100,	  50	  and	  100	  μm);	  E)	  Ac-­‐LDL	  uptake	   (Scale	  bar	  =	  50	  μm);	  F)	  Phase	   contrast	  photomicrograph	  of	  differentiated	  cells	  cultured	  in	  Matrigel	  for	  24h	  (Scale	  bar	  =	  150	  μm).	  
Figure	  S-­‐7	  –	  Morphology	  of	  CD34+-­‐derived	   cells,	  21	   days	  after	  plating.	  Big	  agglomerates	  of	  round	  cells	  were	  formed.	  Scale	  bar	  =	  200	  μm.	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Figure	   S-­‐8	   –	   HUVECs	  were	   efficiently	   stained	   with	   CellTracker	   Green	   and	  MSCs	   with	   CellTracker	  
Blue.	  No	  double	  staining	  was	  detected	  in	  separated	  channels,	  although	  only	  the	  periphery	  of	  the	  disk	  could	  be	  focused.	  Sample	  was	  visualized	  under	  inverted	  fluorescence	  microscope.	  Scale	  bar=150	  μm.	  
